<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article article-type="research-article" dtd-version="1.2" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">75829</article-id><article-id pub-id-type="doi">10.7554/eLife.75829</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>A tonic nicotinic brake controls spike timing in striatal spiny projection neurons</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes" id="author-261872"><name><surname>Matityahu</surname><given-names>Lior</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-6115-8608</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-261873"><name><surname>Malgady</surname><given-names>Jeffrey M</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-1129-2155</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-261874"><name><surname>Schirelman</surname><given-names>Meital</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-9081-7019</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-261875"><name><surname>Johansson</surname><given-names>Yvonne</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-9781-9204</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="pa1">‡</xref><xref ref-type="other" rid="fund7"/><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-261876"><name><surname>Wilking</surname><given-names>Jennifer A</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-6488-412X</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-46437"><name><surname>Silberberg</surname><given-names>Gilad</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-9964-505X</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund6"/><xref ref-type="other" rid="fund8"/><xref ref-type="other" rid="fund9"/><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" corresp="yes" id="author-254708"><name><surname>Goldberg</surname><given-names>Joshua A</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-5740-4087</contrib-id><email>joshua.goldberg2@mail.huji.ac.il</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" corresp="yes" id="author-115932"><name><surname>Plotkin</surname><given-names>Joshua L</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6232-7613</contrib-id><email>joshua.plotkin@stonybrook.edu</email><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf2"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03qxff017</institution-id><institution>Department of Medical Neurobiology, Institute of Medical Research Israel–Canada, The Faculty of Medicine, The Hebrew University of Jerusalem</institution></institution-wrap><addr-line><named-content content-type="city">Jerusalem</named-content></addr-line><country>Israel</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05qghxh33</institution-id><institution>Department of Neurobiology and Behavior, Center for Nervous System Disorders, Stony Brook University School of Medicine, Stony Brook University</institution></institution-wrap><addr-line><named-content content-type="city">Stony Brook</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/056d84691</institution-id><institution>Department of Neuroscience, Karolinska Institutet</institution></institution-wrap><addr-line><named-content content-type="city">Stockholm</named-content></addr-line><country>Sweden</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Ding</surname><given-names>Jun</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00f54p054</institution-id><institution>Stanford University</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Huguenard</surname><given-names>John R</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00f54p054</institution-id><institution>Stanford University School of Medicine</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn><fn fn-type="present-address" id="pa1"><label>‡</label><p>Sainsbury Wellcome Centre for Neural Circuits and Behaviour, University College London, London, United Kingdom</p></fn></author-notes><pub-date date-type="publication" publication-format="electronic"><day>17</day><month>05</month><year>2022</year></pub-date><pub-date pub-type="collection"><year>2022</year></pub-date><volume>11</volume><elocation-id>e75829</elocation-id><history><date date-type="received" iso-8601-date="2021-11-24"><day>24</day><month>11</month><year>2021</year></date><date date-type="accepted" iso-8601-date="2022-05-15"><day>15</day><month>05</month><year>2022</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at bioRxiv.</event-desc><date date-type="preprint" iso-8601-date="2021-11-03"><day>03</day><month>11</month><year>2021</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2021.11.02.466870"/></event></pub-history><permissions><copyright-statement>© 2022, Matityahu, Malgady, Schirelman et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Matityahu, Malgady, Schirelman et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-75829-v2.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-75829-figures-v2.pdf"/><abstract><p>Striatal spiny projection neurons (SPNs) transform convergent excitatory corticostriatal inputs into an inhibitory signal that shapes basal ganglia output. This process is fine-tuned by striatal GABAergic interneurons (GINs), which receive overlapping cortical inputs and mediate rapid corticostriatal feedforward inhibition of SPNs. Adding another level of control, cholinergic interneurons (CINs), which are also vigorously activated by corticostriatal excitation, can disynaptically inhibit SPNs by activating α4β2 nicotinic acetylcholine receptors (nAChRs) on various GINs. Measurements of this disynaptic inhibitory pathway, however, indicate that it is too slow to compete with direct GIN-mediated feedforward inhibition. Moreover, functional nAChRs are also present on populations of GINs that respond only weakly to phasic activation of CINs, such as parvalbumin-positive fast-spiking interneurons (PV-FSIs), making the overall role of nAChRs in shaping striatal synaptic integration unclear. Using acute striatal slices from mice we show that upon synchronous optogenetic activation of corticostriatal projections blockade of α4β2 nAChRs shortened SPN spike latencies and increased postsynaptic depolarizations. The nAChR-dependent inhibition was mediated by downstream GABA release, and data suggest that the GABA source was not limited to GINs that respond strongly to phasic CIN activation. In particular, the observed decrease in spike latency caused by nAChR blockade was associated with a diminished frequency of spontaneous inhibitory postsynaptic currents in SPNs, a parallel hyperpolarization of PV-FSIs, and was occluded by pharmacologically preventing cortical activation of PV-FSIs. Taken together, we describe a role for tonic (as opposed to phasic) activation of nAChRs in striatal function. We conclude that tonic activation of nAChRs by CINs maintains a GABAergic brake on cortically-driven striatal output by ‘priming’ feedforward inhibition, a process that may shape SPN spike timing, striatal processing, and synaptic plasticity.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>striatal microcircuitry</kwd><kwd>tonically active neurons</kwd><kwd>mecamylamine</kwd><kwd>DHβE</kwd><kwd>Naspm</kwd><kwd>channelrhodopsin-2</kwd><kwd>methyllycaconitine</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100006221</institution-id><institution>BSF</institution></institution-wrap></funding-source><award-id>2017020</award-id><principal-award-recipient><name><surname>Goldberg</surname><given-names>Joshua A</given-names></name><name><surname>Plotkin</surname><given-names>Joshua L</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003977</institution-id><institution>Israel Science Foundation</institution></institution-wrap></funding-source><award-id>154/14</award-id><principal-award-recipient><name><surname>Goldberg</surname><given-names>Joshua A</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000781</institution-id><institution>European Research Council</institution></institution-wrap></funding-source><award-id>Consolidator grant 646880</award-id><principal-award-recipient><name><surname>Goldberg</surname><given-names>Joshua A</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000065</institution-id><institution>National Institute of Neurological Disorders and Stroke</institution></institution-wrap></funding-source><award-id>R01 NS104089/NINDS</award-id><principal-award-recipient><name><surname>Plotkin</surname><given-names>Joshua L</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000065</institution-id><institution>National Institute of Neurological Disorders and Stroke</institution></institution-wrap></funding-source><award-id>NS022061/NINDS</award-id><principal-award-recipient><name><surname>Plotkin</surname><given-names>Joshua L</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003792</institution-id><institution>Hjärnfonden</institution></institution-wrap></funding-source><award-id>FO2021-0333</award-id><principal-award-recipient><name><surname>Silberberg</surname><given-names>Gilad</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003792</institution-id><institution>Hjärnfonden</institution></institution-wrap></funding-source><award-id>PS2020-0020</award-id><principal-award-recipient><name><surname>Johansson</surname><given-names>Yvonne</given-names></name></principal-award-recipient></award-group><award-group id="fund8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004359</institution-id><institution>Vetenskapsrådet</institution></institution-wrap></funding-source><award-id>2019-01254</award-id><principal-award-recipient><name><surname>Silberberg</surname><given-names>Gilad</given-names></name></principal-award-recipient></award-group><award-group id="fund9"><funding-source><institution-wrap><institution>Wallenberg Academy Fellowship</institution></institution-wrap></funding-source><award-id>KAW 2017.0273</award-id><principal-award-recipient><name><surname>Silberberg</surname><given-names>Gilad</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>A novel mechanism describes how tonic activation of nicotinic acetylcholine receptors can modulate the timing of striatal output by priming feedforward inhibition.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>As the main input nucleus of the basal ganglia, the striatum receives convergent cortical synaptic information, generating a computationally transformed interpretation of this information and relaying it to intermediate and output nuclei of the basal ganglia. Striatal output is carried exclusively by GABAergic striatal spiny projection neurons (SPNs), which account for ~95% of all striatal neurons (<xref ref-type="bibr" rid="bib34">Gerfen and Surmeier, 2011</xref>; <xref ref-type="bibr" rid="bib74">Silberberg and Bolam, 2015</xref>). The remaining 5% of striatal neurons are interneurons, most of which are GABAergic interneurons (GINs). There are several molecularly distinct classes of GINs that exhibit diverse intrinsic firing patterns and patterns of intrastriatal connectivity (<xref ref-type="bibr" rid="bib80">Tepper et al., 2010</xref>; <xref ref-type="bibr" rid="bib58">Muñoz-Manchado et al., 2018</xref>; <xref ref-type="bibr" rid="bib13">Assous and Tepper, 2019</xref>). In the context of feedforward cortico- and thalamo-striatal transmission, the GINs’ function lies in the feedforward inhibition they provide to SPNs (<xref ref-type="bibr" rid="bib79">Tepper et al., 2004b</xref>; <xref ref-type="bibr" rid="bib12">Assous et al., 2017</xref>). Such inhibition can fashion striatal output by perturbing the precise timing of SPNs or prevent their spiking altogether. The only non-GINs are the large, aspiny, cholinergic interneurons (CINs) (<xref ref-type="bibr" rid="bib25">DiFiglia, 1987</xref>; <xref ref-type="bibr" rid="bib78">Tepper and Bolam, 2004a</xref>, <xref ref-type="bibr" rid="bib65">Plotkin and Goldberg, 2019</xref>; <xref ref-type="bibr" rid="bib66">Poppi et al., 2021</xref>). Despite their small numbers (approximately 1% of striatal neurons), the acetylcholine (ACh) they release influences the entire striatal microcircuitry. A single CIN axon can cover a third of the striatum (in linear dimension) and has ACh release sites every few micrometers (<xref ref-type="bibr" rid="bib25">DiFiglia, 1987</xref>). In fact, the striatum has the highest expression of cholinergic markers in the entire CNS (<xref ref-type="bibr" rid="bib54">Mesulam et al., 1992</xref>; <xref ref-type="bibr" rid="bib21">Contant et al., 1996</xref>). CINs are autonomous pacemakers (<xref ref-type="bibr" rid="bib15">Bennett and Wilson, 1999</xref>) that are largely identified as the tonically active neurons (TANs) of the striatum (<xref ref-type="bibr" rid="bib46">Kimura et al., 1984</xref>; <xref ref-type="bibr" rid="bib86">Wilson et al., 1990</xref>; <xref ref-type="bibr" rid="bib7">Aosaki et al., 1994</xref>; <xref ref-type="bibr" rid="bib8">Aosaki et al., 1995</xref>; <xref ref-type="bibr" rid="bib56">Morris et al., 2004</xref>), firing 3–10 spikes/s in vivo. On the backdrop of this ongoing discharge, the main signal they convey in vivo is a pause in response to primary reward or salient stimuli associated with reward (<xref ref-type="bibr" rid="bib7">Aosaki et al., 1994</xref>; <xref ref-type="bibr" rid="bib56">Morris et al., 2004</xref>; <xref ref-type="bibr" rid="bib38">Goldberg and Reynolds, 2011</xref>; <xref ref-type="bibr" rid="bib10">Apicella, 2017</xref>). The duration of the pause in response to a brief conditioned sensory stimulus is on the order of 200–300 ms (<xref ref-type="bibr" rid="bib46">Kimura et al., 1984</xref>; <xref ref-type="bibr" rid="bib68">Raz et al., 1996</xref>; <xref ref-type="bibr" rid="bib9">Apicella et al., 1997</xref>).</p><p>CINs regulate SPNs in three main ways. The best characterized regulation is exerted via muscarinic ACh receptors (mAChRs). Activation of presynaptic and postsynaptic mAChRs on SPNs modulates synaptic transmission, synaptic plasticity, and the intrinsic excitability of SPNs by modulating various voltage-activated Ca<sup>2+</sup> and K<sup>+</sup> channels (<xref ref-type="bibr" rid="bib5">Akins et al., 1990</xref>; <xref ref-type="bibr" rid="bib20">Calabresi et al., 1999</xref>; <xref ref-type="bibr" rid="bib33">Gabel and Nisenbaum, 1999</xref>; <xref ref-type="bibr" rid="bib24">Day et al., 2008</xref>; <xref ref-type="bibr" rid="bib39">Goldberg et al., 2012</xref>; <xref ref-type="bibr" rid="bib90">Zucca et al., 2018</xref>). CINs influence SPNs via nicotinic ACh receptors (nAChRs) as well, albeit indirectly. Activation of nAChRs on striatal dopaminergic fibers can evoke dopamine (DA) release (<xref ref-type="bibr" rid="bib88">Zhou et al., 2001</xref>; <xref ref-type="bibr" rid="bib19">Cachope et al., 2012</xref>; <xref ref-type="bibr" rid="bib83">Threlfell et al., 2012</xref>; <xref ref-type="bibr" rid="bib51">Liu et al., 2022</xref>) which, in turn, can modulate the intrinsic excitability of SPNs and synaptic transmission and plasticity at synaptic inputs. All of the above influences involve GPCR-linked ACh and DA receptors, which means that they are unlikely to dynamically affect the moment-by-moment processing and transmission of excitatory inputs to SPNs. Indeed, a recent study in which CINs were silenced optogenetically in vivo has put a lower bound on how fast mAChR-mediated effects can come into play. When CINs are synchronously silenced for over 500 ms, SPNs begin to show signs of mAChR-dependent reductions in excitability. However, that effect comes into play only after a 400 ms delay (<xref ref-type="bibr" rid="bib90">Zucca et al., 2018</xref>). The only known mechanisms by which CINs can rapidly affect SPN activity (sooner than 400 ms) involve nicotinic or muscarinic modulation of synaptic glutamate release or α4β2 nAChR-dependent GABA release onto the SPNs’ ionotropic GABA<sub>A</sub> receptors (<xref ref-type="bibr" rid="bib61">Pakhotin and Bracci, 2007</xref>; <xref ref-type="bibr" rid="bib29">English et al., 2011</xref>; <xref ref-type="bibr" rid="bib30">Faust et al., 2015</xref>; <xref ref-type="bibr" rid="bib31">Faust et al., 2016</xref>; <xref ref-type="bibr" rid="bib12">Assous et al., 2017</xref>; <xref ref-type="bibr" rid="bib14">Assous, 2021</xref>). The α4β2 nAChRs that drive disynaptic GABA release are located on GINs (<xref ref-type="bibr" rid="bib29">English et al., 2011</xref>; <xref ref-type="bibr" rid="bib30">Faust et al., 2015</xref>), and on dopaminergic nigrostriatal terminals (<xref ref-type="bibr" rid="bib60">Nelson et al., 2014b</xref>).</p><p>Because CINs receive massive excitatory cortical and thalamic input (<xref ref-type="bibr" rid="bib49">Lapper and Bolam, 1992</xref>; <xref ref-type="bibr" rid="bib82">Thomas et al., 2000</xref>; <xref ref-type="bibr" rid="bib53">Mamaligas et al., 2019</xref>), it is conceivable that their disynaptic inhibition of SPNs comes into play during bouts of cortical or thalamic activity. However, this raises a conceptual problem. Because cortex and thalamus can activate feedforward inhibition to SPNs via various striatal GINs (e.g., cortex → GIN → SPN), what is gained by recruiting an additional pathway that is necessarily slower and less reliable due to its additional synapse (e.g., cortex → CIN → GIN → SPN)? Moreover, what is the role of nAChRs on GINs, such as the parvalbumin-positive fast-spiking interneurons (PV-FSIs) that only weakly respond to direct activation of CINs (<xref ref-type="bibr" rid="bib29">English et al., 2011</xref>; <xref ref-type="bibr" rid="bib59">Nelson et al., 2014a</xref>; <xref ref-type="bibr" rid="bib60">Nelson et al., 2014b</xref>)? This conceptual problem exists only if we assume that the role of CINs in modulating SPN function through the activation of nAChRs is anchored around their phasic activation by excitatory afferents. In this study we demonstrate that ongoing CIN activity exerts a constant brake on SPN excitation and spike initiation via tonically activated α4β2 nAChRs located on discrete populations of GINs. We uncover these nicotinic effects using transgenic mice that nominally express channelrhodopsin-2 (ChR2) in corticostriatal fibers (<xref ref-type="bibr" rid="bib11">Arenkiel et al., 2007</xref>). Activation of these fibers creates a competition between monosynaptic cortical excitation and polysynaptic feedforward inhibition to SPNs. We show that nAChRs embedded in a GABAergic postsynaptic pathway are capable of controlling SPN spike timing with millisecond precision.</p></sec><sec id="s2" sec-type="results"><title>Results</title><p>To interrogate microcircuit-level responses of SPNs to cortical excitation of the striatum, we generated acute ex vivo brain slices from Thy1-ChR2 mice, which nominally express ChR2 in cortical neurons (<xref ref-type="bibr" rid="bib11">Arenkiel et al., 2007</xref>; <xref ref-type="bibr" rid="bib3">Aceves Buendia et al., 2019</xref>). Full-field optogenetic stimulation with a 470 nm LED engaged corticostriatal afferents and generated in SPNs either: excitatory postsynaptic potentials (EPSPs) for low LED intensities, or – in the suprathreshold condition – an action potential (AP) followed by an afterdepolarization (ADP) lasting 10 s of milliseconds (<xref ref-type="fig" rid="fig1">Figure 1a</xref>). While ADPs were kinetically similar to EPSPs under our experimental conditions, we explicitly separated these measures because ADPs (1) can be modulated by similar cortically activated local striatal circuits that shape SPN spike timing and (2) peak closer to spike threshold, positioning them to influence subsequent spike generation (<xref ref-type="bibr" rid="bib32">Flores-Barrera et al., 2010</xref>). Blockade of nAChRs with mecamylamine (mec; 10 µM) enhanced SPN responses to cortical stimulation (<xref ref-type="fig" rid="fig1">Figure 1b</xref>), as it shortened AP latency (<xref ref-type="fig" rid="fig1">Figure 1c</xref>) and increased both the ADP (<xref ref-type="fig" rid="fig1">Figure 1d</xref>) and subthreshold EPSP amplitudes (<xref ref-type="fig" rid="fig1">Figure 1e</xref>). Because this suggests that under these conditions EPSPs and ADPs are mechanistically similar, the remainder of this study focuses on SPN AP latency and ADP amplitude generated by just-suprathreshold LED stimulation, which facilitated comparison among cells. The effects of mecamylamine were replicated in the presence of the α4β2 nAChR-selective antagonist, dihydro-β-erythroidine hydrobromide (DHβE) (10 µM, AP latency: n=8 SPNs, p=7.8·10<sup>–3</sup>, signed-rank test (SRT); ADP amplitude: n=7 SPNs, p=0.03, SRT; <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). Because the resting membrane potential of SPNs is very hyperpolarized compared to the depolarized potential from which spikes typically occur in vivo (<xref ref-type="bibr" rid="bib85">Wilson and Groves, 1981</xref>; <xref ref-type="bibr" rid="bib76">Stern et al., 1998</xref>), we repeated the experiment while holding the SPN with a constant positive current injection in the just-subthreshold region (e.g., in the –55 to –50 mV range). Mecamylamine shortened the latency to AP from this depolarized potential as well (<xref ref-type="fig" rid="fig1">Figure 1f–g</xref>). We note that ADPs were not consistently present under these conditions, likely because the depolarized potential typically eclipsed ADP amplitudes observed from rest.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Nicotinic acetylcholine receptor (nAChR)-dependent inhibition and delay of spike latency in spiny projection neurons (SPNs) activated by corticostriatal fibers.</title><p>(<bold>A</bold>) Left: diagram of recording configuration. An SPN is patched in an acute slice from a Thy1-ChR2 mouse. Right: 1-ms-long 470 nm LED pulse of increasing intensity generates excitatory postsynaptic potentials (EPSPs), or an AP followed by an afterdepolarization (ADP) in an SPN. (<bold>B</bold>) Examples of the effect of 10 µM mecamylamine (mec), an nAChR antagonist, on EPSP amplitude (dashed) or spike latency and ADP amplitude (solid). (<bold>C–E</bold>) Mecamylamine significantly shortens spike latencies (p=4.8·10<sup>–4</sup>, n=12 SPNs, signed-rank test [SRT]) (<bold>C</bold>), as well as ADP (p=2.4·10<sup>–3</sup>, n=12 SPNs, SRT) (<bold>D</bold>) and EPSP (p=0.03, n=6 SPNs, SRT) (<bold>E</bold>) amplitudes. (<bold>F</bold>) Examples of the effect of mecamylamine on latency of a spike triggered synaptically from a depolarized potential with an LED pulse. (<bold>G</bold>) Mecamylamine significantly shortens spike latencies in SPNs held at a depolarized potential (p=0.03, n=6 SPNs, SRT). Two-sided Wilcoxon SRT. ***p&lt;0.001, **p&lt;0.01, *p&lt;0.05.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-75829-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Dihydro-β-erythroidine hydrobromide (DHβE) mimics the effect of mecamylamine on striatal spiny projection neuron (SPN) spike latency and afterdepolarization (ADP) amplitude.</title><p>(<bold>A–B</bold>) DHβE significantly shortens spike latencies (p=7.8·10<sup>–3</sup>, n=8 SPNs, signed-rank test [SRT]) (<bold>A</bold>) and ADP amplitudes (p=0.03, n=8 SPNs, SRT) (<bold>B</bold>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-75829-fig1-figsupp1-v2.tif"/></fig></fig-group><p>Because SPNs themselves do not express nAChRs, the action of mecamylamine must be indirect. Functional nAChRs are expressed at multiple loci of the striatal circuit, including afferent axonal terminals and intrastriatal interneurons (<xref ref-type="bibr" rid="bib60">Nelson et al., 2014b</xref>; <xref ref-type="bibr" rid="bib31">Faust et al., 2016</xref>; <xref ref-type="bibr" rid="bib2">Abudukeyoumu et al., 2019</xref>; <xref ref-type="bibr" rid="bib14">Assous, 2021</xref>; <xref ref-type="bibr" rid="bib1">Abbondanza et al., 2022</xref>; <xref ref-type="bibr" rid="bib55">Morgenstern et al., 2022</xref>). While the broad antagonistic actions of mecamylamine and DHβE should block nicotinic receptors at most of these loci, α7 nAChRs, which are predominantly expressed at corticostriatal axon terminals, may be spared (<xref ref-type="bibr" rid="bib75">Solinas et al., 2007</xref>; <xref ref-type="bibr" rid="bib50">Licheri et al., 2018</xref>; <xref ref-type="bibr" rid="bib14">Assous, 2021</xref>). Indeed, mecamylamine did not have a significant effect on the strength or release probability of corticostriatal glutamatergic afferents, as measured by local electrical stimulation (<xref ref-type="fig" rid="fig2">Figure 2A-C</xref>). Blockade of α7 nAChRs with the more selective α7 antagonist methyllycaconitine (MLA; 5 µM) did not significantly alter corticostriatal afferent strength or release probability either (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>), suggesting that nAChRs on these synapses are not poised to track tonic ACh release.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Mecamylamine does not alter release probability of excitatory synaptic inputs.</title><p>(<bold>A</bold>) Example responses of an striatal spiny projection neuron (SPN) to paired pulse stimulation (evoked by two local electrical stimuli separated by 50 ms), before and in the presence of mecamylamine (10 µM). (<bold>B</bold>) Mecamylamine had no effect on the excitatory postsynaptic current (EPSC) amplitude evoked by the first paired stimulus (<bold>P1</bold>) (p=0.59, n=15 SPNs, signed-rank test [SRT]). (<bold>C</bold>) Mecamylamine had no effect on the paired pulse ratio (PPR) (P2/P1, p=0.33, n=15 SPNs, SRT).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-75829-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Methyllycaconitine (MLA) does not alter release probablity of excitatory synaptic inputs.</title><p>(<bold>A</bold>) Example responses of a striatal spiny projection neuron (SPN) to paired pulse stimulation (electrical stimuli separated by 50 ms) before and in the presence of MLA (5 µM). (<bold>B</bold>) MLA had no effect on the excitatory postsynaptic current (EPSC) amplitude evoked by the first paired stimulus (<bold>P1</bold>) (p=0.1475, n=11, signed-rank test [SRT]). (<bold>C</bold>) MLA had no effect on the paired pulse ratio (PPR) (P2/P1, p&gt;0.9999, n=11, SRT).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-75829-fig2-figsupp1-v2.tif"/></fig></fig-group><p>The lack of an effect of mecamylamine on presynaptic release probability suggests that mecamylamine shapes SPN spike timing through postsynaptically expressed nicotinic receptors within the striatum. CINs form a disynaptic circuit with SPNs, which is mediated by neuropeptide Y-neurogliaform (NPY-NGF) GINs (and perhaps other classes of nAChR-expressing GINs) in an nAChR-dependent manner (<xref ref-type="bibr" rid="bib29">English et al., 2011</xref>; <xref ref-type="bibr" rid="bib28">Elghaba et al., 2016</xref>; <xref ref-type="bibr" rid="bib31">Faust et al., 2016</xref>; <xref ref-type="bibr" rid="bib12">Assous et al., 2017</xref>; <xref ref-type="bibr" rid="bib81">Tepper et al., 2018</xref>). Consistent with the involvement of such an inhibitory polysynaptic circuit, we note that blockade of nAChRs reduced the latency of synaptically evoked spikes in SPNs that were held just-subthreshold even if the SPN membrane potential fell (<xref ref-type="fig" rid="fig1">Figure 1f</xref>), an observation that could be accounted for by GABA receptor-mediated shunting (<xref ref-type="bibr" rid="bib41">Gustafson et al., 2006</xref>). Accordingly, blockade of GABAergic transmission with the GABA<sub>A</sub> and GABA<sub>B</sub> receptor antagonists SR-95531 (10 µM) and CGP-55845 (2 µM), respectively, mimicked the effect of mecamylamine on spike timing and ADP amplitude (<xref ref-type="fig" rid="fig3">Figure 3a–c</xref>). Blockade of GABA receptors fully occluded mecamylamine’s effect on both spike latency and ADP amplitude (<xref ref-type="fig" rid="fig3">Figure 3a–c</xref>), further implicating a CIN-GIN-SPN disynaptic circuit in mediating the actions of nAChRs. Strikingly, mecamylamine prevented GABA receptor antagonists from further advancing spike timing or enhancing ADP amplitude, suggesting that nAChR activation can saturate GABAergic inhibition (<xref ref-type="fig" rid="fig3">Figure 3d–f</xref>).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>The nicotinic acetylcholine receptor (nAChR)-dependent inhibition of corticostriatal striatal spiny projection neuron (SPN) activation is mediated through and saturates GABAergic inhibition.</title><p>(<bold>A</bold>) Example of the occlusion of the mecamylamine effect on optogenetic synaptic activation of SPNs by receptor (GABAR) antagonists, 10 µM SR-95531 (GABA<sub>A</sub>R antagonist) and 2 µM CGP-55845 (GABA<sub>B</sub>R antagonist). Distribution of spike latencies (<bold>B</bold>) and ADP amplitude (<bold>C</bold>) in response to application of GABAR antagonists followed by mecamylamine, showing that application of GABAR antagonist significantly shortens the action potential (AP) latency (p=4.6·10<sup>–3</sup>, n=13 SPNs, signed-rank test [SRT]) and enhancement of the ADP amplitude (p=2.4·10<sup>–4</sup>, n=13 SPNs, SRT). In contrast, the subsequent mecamylamine application fails to further shorten the AP latency (p=0.0625, n=5 SPNs, SRT) or further enhance the ADP amplitude (p=1, n=5, SRT). (<bold>D</bold>) Example of how the mecamylamine effect saturates the GABAergic inhibition of the optogenetic synaptic activation of SPNs. (<bold>E–F</bold>) Distribution of spike latencies (<bold>E</bold>) and ADP amplitude (<bold>F</bold>) in response to application of mecamylamine followed by GABAR antagonists, showing that the subsequent application of GABAR antagonists fails to further shorten the AP latency (p=0.25, n=5 SPNs, SRT) or further enhance the ADP amplitude (p=0.44, n=5 SPNs, SRT).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-75829-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>ChR2 expression is not observed in cortical or striatal GABAergic neurons in Thy1-ChR2 mice.</title><p>(<bold>A</bold>) Confocal images from the sensorimotor cortex, auditory (<bold>A1</bold>) cortex, striatum, and globus pallidus (GP) of a Thy1-ChR2 mouse. Tissue was stained for glutamic acid decarboxylase (GAD) or somatostatin (SOM); colocalization of ChR2 (green) and GAD or SOM was not observed. ChR2 expression was observed in a population of GP neurons (in some mice, EYFP aggregates could be observed in the cortex). (<bold>B–C</bold>) Example recordings of a striatal spiny projection neuron (SPN) in the presence of the AMPA and NMDA receptor blockers DNQX and D-APV reveal the presence of an optogenetically generated monosynaptic inhibitory postsynaptic current (IPSC) in SPNs from Thy1-ChR2 mice. Arrow indicates compound action current in ChR2-laden axons (<xref ref-type="bibr" rid="bib77">Tanimura et al., 2016</xref>) (<bold>B</bold>). This monosynaptic IPSC, however, was insensitive to mecamylamine (glutamate blockers vs. mecamylamine [mec]: p=0.578; glutamate blockers + mec vs. GABA receptor blockers: p=0.0156; n=7, signed-rank test [SRT]) (<bold>C</bold>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-75829-fig3-figsupp1-v2.tif"/></fig></fig-group><p>While SPN spiking was driven by convergently activated corticostriatal inputs in the above experiments, activation of monosynaptic GABAergic inputs due to ectopic expression of ChR2 cannot necessarily be ruled out. This is an important point, because mecamylamine’s mechanism of action involves nAChRs embedded in a GABAergic circuit. Immunohistochemical staining did not show any evidence of ChR2 expression in GABAergic neurons within the cortex or striatum, including somatostatin (SOM)-expressing cortical neurons known to directly innervate SPNs (<xref ref-type="bibr" rid="bib71">Rock et al., 2016</xref>), but did reveal ChR2-positive neurons in the globus pallidus (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). This is in addition to observations of ChR2 expression in GABAergic neurons of the substantia nigra pars reticulata in Thy1-ChR2 mice (<xref ref-type="bibr" rid="bib62">Pan et al., 2013</xref>; <xref ref-type="bibr" rid="bib43">Higgs and Wilson, 2017</xref>; <xref ref-type="bibr" rid="bib84">Tiroshi and Goldberg, 2019</xref>). Indeed, blockade of glutamate receptors to eliminate feedforward inhibition revealed the presence of an optogenetically evoked monosynaptic GABAergic input to SPNs (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). This monosynaptic input was insensitive to mecamylamine, however, making it unlikely to mediate the observed effect of nAChRs on SPN spike timing (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>).</p><p>CINs receive converging excitatory inputs from the thalamus as well as the cortex (<xref ref-type="bibr" rid="bib49">Lapper and Bolam, 1992</xref>; <xref ref-type="bibr" rid="bib82">Thomas et al., 2000</xref>). Indeed, targeted recordings from CINs confirmed that they are robustly engaged by our corticostriatal stimulation protocol, even displaying a lower stimulation threshold and shorter average delay to spike than SPNs (<xref ref-type="fig" rid="fig4">Figure 4a–c</xref>). Despite the observed high fidelity and speed of cortically evoked CIN spiking, a comparison of the temporal dynamics of synchronous cortical engagement of SPN inhibition (latency of approximately 5 ms, <xref ref-type="fig" rid="fig5">Figure 5a</xref>) vs. synchronous CIN engagement of GINs (latency of approximately 11 ms, <xref ref-type="bibr" rid="bib29">English et al., 2011</xref>; <xref ref-type="bibr" rid="bib60">Nelson et al., 2014b</xref>) shows that phasic activation of CINs is still not sufficiently fast to account for the mecamylamine-induced spike delay we observed in SPNs (<xref ref-type="fig" rid="fig5">Figure 5b</xref>). In particular, even if there are sufficient numbers of CINs that respond <italic>instantaneously</italic> to cortical activation due to their ongoing activity, the earliest latency at which their phasic inhibition can influence SPNs is 11 ms later (<xref ref-type="bibr" rid="bib29">English et al., 2011</xref>; <xref ref-type="bibr" rid="bib60">Nelson et al., 2014b</xref>). However, SPN spikes are being delayed beginning 5 ms after stimulation (<xref ref-type="fig" rid="fig5">Figure 5c</xref> magenta), which cannot be explained by phasic CIN activation.</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>The autonomous firing of cholinergic interneurons (CINs) enables them to respond more rapidly and vigorously than striatal spiny projection neurons (SPNs) to feedforward corticostriatal excitation.</title><p>(<bold>A</bold>) Example of the autonomous discharge of a CIN recorded in cell-attached configuration (top) and the distribution of firing rates (bottom, n=15 CINs) in an acute striatal slice. (<bold>B</bold>) Peristimulus time histograms (PSTHs) of a CIN in response to optogenetic activation of corticostriatal fibers at various 470 nm LED intensities as compared to the amplitude of the excitatory postsynaptic potentials (EPSPs) evoked in a nearby SPN (insets), demonstrating that CINs are much more sensitive than SPNs to cortical activation. (<bold>C</bold>) Cumulative distribution of the latency to first spike of CINs recorded in cell-attached mode (green, n=8 CINs) as compared to the latency to first spike in an SPN recorded (from a resting state) in the whole-cell mode (n=12), before (black) and after (magenta) application of mecamylamine.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-75829-fig4-v2.tif"/></fig><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Latency of feedforward GABAergic inhibitory postsynaptic currents (IPSCs) in striatal spiny projection neurons (SPNs) activated synaptically by corticostriatal fibers.</title><p>(<bold>A</bold>) Left: IPSCs recorded in an SPN held at +10 mV before (black) and after (red) application of GABAR antagonists, reveals GABA-sensitive (purple) IPSC. Right: zoom-in of the GABAergic IPSCs enables estimation (fit of diagonal black line) of the latency of the feedforward GABA-sensitive inhibition. (<bold>B</bold>) Distribution of the latency of feedforward GABAergic inhibition to SPNs in the Thy1-ChR2 mouse (n=7 SPNs). (<bold>C</bold>) Schematic demonstrating that the feedforward GABAergic inhibition precedes the earliest timing of feedforward cholinergic disynaptic inhibition of SPNs, indicating that phasic activation of CINs cannot explain the nicotinic acetylcholine receptor (nAChR)-dependent delay of spike latency.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-75829-fig5-v2.tif"/></fig><p>If phasic activation of nAChRs by synaptically evoked CIN activity cannot account for the observed delay in SPN spike initiation (due to the necessarily slow nature of the CIN-GIN-SPN disynaptic signal), how does blocking nAChRs advance synaptically evoked SPN spiking? Given the autonomous pacemaking nature of CINs, perhaps the explanation is that <italic>tonic</italic>, rather than phasic, activation of nAChRs is key to the phenomenon. There are three obvious mechanisms that could be at play in this scenario: (1) ongoing nAChR activation (either tonic or phasic activation that is not time-locked with the corticostriatal stimulation event leading to SPN spiking) may decrease SPN intrinsic excitability indirectly, likely by altering ongoing neuromodulator release (<xref ref-type="bibr" rid="bib89">Zhou et al., 2002</xref>; <xref ref-type="bibr" rid="bib70">Rice and Cragg, 2004</xref>); (2) the effect on SPN spiking may be a non-specific drug effect of mecamylamine (this is unlikely, since DHβE had the same effects); or (3) <italic>tonic</italic> activation of somatodendritic nAChRs may produce an ongoing depolarization of GINs, ultimately priming or accentuating corticostriatal feedforward inhibition.</p><p>To test the possibility that blockade of ongoing nAChR activation increases SPN excitability, we measured the current-voltage (IV) relationship of SPNs before and during mecamylamine application. While there is no indication that our detected effect of mecamylamine on spike timing or ADP amplitude is bimodal and specific to direct pathway SPNs (dSPNs) or indirect pathway SPNs (iSPNs), dSPNs and iSPNs display differences in basal excitability (<xref ref-type="bibr" rid="bib35">Gertler et al., 2008</xref>), which can complicate interpretation. We therefore performed these experiments in transgenic mice where dSPNs and iSPNs could be identified by their fluorescent label (<xref ref-type="bibr" rid="bib73">Shuen et al., 2008</xref>; <xref ref-type="bibr" rid="bib4">Ade et al., 2011</xref>; <xref ref-type="fig" rid="fig6">Figure 6a</xref>). Mecamylamine had no significant effect on the resting membrane potential or rheobase current of either SPN type (<xref ref-type="fig" rid="fig6">Figure 6b and c</xref>). Furthermore, mecamylamine did not decrease the time to spike in response to somatic rheobase current injection or the latency to first spike in an AP train induced by suprathreshold somatic current injection (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>). Given that most data to this point came from pooled populations of SPNs, and that we observed no SPN-type-specific effects of mecamylamine on SPN excitability, we performed additional analysis on pooled SPN data. While rheobase currents were unaffected, mecamylamine decreased the responsiveness to several sub-rheobase amplitude currents, arguing that if anything mecamylamine may <italic>decrease</italic> the excitability of SPNs in some regards (<xref ref-type="fig" rid="fig6">Figure 6d</xref>). Mecamylamine had no effect on the firing rate of SPNs (<xref ref-type="fig" rid="fig6">Figure 6e</xref>), nor did it alter IV properties of unidentified SPNs recorded from Thy1-ChR2 mice (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>). Taken together, reduced spike latency induced by nAChR blockade cannot be explained by changes in SPN intrinsic excitability.</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Striatal spiny projection neuron (SPN) intrinsic excitability is not increased by nicotinic acetylcholine receptor (nAChR) blockade.</title><p>(<bold>A</bold>) Example current-voltage (IV) traces of direct pathway SPNs (dSPNs) and indirect pathway SPNs (iSPNs) in the absence and presence of 10 µM mecamylamine. (<bold>B</bold>) Left: resting membrane potential of dSPNs (black) and iSPNs (blue) in the absence and presence of mecamylamine (all SPNs: p=0.43, n=13; dSPNs: p=0.16, n=7; iSPNs: p=0.87, n=6; signed-rank test [SRT]). Right: percent change in resting membrane potential after mecamylamine application. (<bold>C</bold>) Left: rheobase current of dSPNs and iSPNs in the absence and presence of mecamylamine (all SPNs: p=0.075, n=13; dSPNs: p=0.5, n=7; iSPNs: p=0.095, n=6; SRT). Right: percent change in rheobase current after mecamylamine application. (<bold>D</bold>) Voltage responses to subthreshold current injections are not enhanced by mecamylamine (F(11,120)=0.86, p=0.58; n=11; two-way ANOVA), though a post hoc Bonferroni test reveals a significant mecamylamine-induced decrease at 50 pA (p&lt;0.05) and 75 pA (p&lt;0.01) current injections. (<bold>E</bold>) Action potential (AP) firing frequencies in response to suprathreshold somatic current injections were unaffected by mecamylamine (F(20,231)=0.43, p=0.99; n=12; two-way ANOVA).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-75829-fig6-v2.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>Mecamylamine does not shorten the latency of striatal spiny projection neuron (SPN) action potentials (APs) induced by somatic current injection, or alter somatic excitability of SPNs from Thy1-ChR2 mice.</title><p>(<bold>A</bold>) Latencies of APs induced by rheobase current injection (which induced only a single spike) in a mixed population of SPNs before and in the presence of mecamylamine (p=0.4238, n=12, signed-rank test [SRT]). (<bold>B</bold>) Latencies of the first AP in a train induced by suprathreshold current injection in a mixed population of SPNs before and in the presence of mecamylamine (p=0 022, n=12, SRT). (<bold>C</bold>) Current-voltage (IV) curves (mean ± SEM) of a mixed population of SPNs from Thy1-ChR2 mice are not affected by mecamylamine.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-75829-fig6-figsupp1-v2.tif"/></fig></fig-group><p>Because mecamylamine did not increase the intrinsic excitability of SPNs, we tested if nAChR blockade attenuated the basal inhibitory GABAergic influence that they are under. Indeed, mecamylamine significantly reduced the frequency of spontaneous inhibitory postsynaptic currents (sIPSCs) in a mixed population of SPNs (<xref ref-type="fig" rid="fig7">Figure 7a–c</xref>). As SPNs lack nAChRs, the source of these attenuated sIPSCs is likely GINs. Indeed, various classes of GINs are excited, and their spontaneous activity is elevated, by tonic activation of nAChRs (<xref ref-type="bibr" rid="bib52">Luo et al., 2013</xref>; <xref ref-type="bibr" rid="bib57">Muñoz-Manchado et al., 2014</xref>, <xref ref-type="bibr" rid="bib44">Ibáñez-Sandoval et al., 2015</xref>, <xref ref-type="bibr" rid="bib28">Elghaba et al., 2016</xref>; <xref ref-type="bibr" rid="bib81">Tepper et al., 2018</xref>). Because PV-FSIs express nAChRs and convey strong feedforward inhibition to SPNs (<xref ref-type="bibr" rid="bib47">Koós and Tepper, 1999</xref>; <xref ref-type="bibr" rid="bib79">Tepper et al., 2004b</xref>; <xref ref-type="bibr" rid="bib64">Planert et al., 2010</xref>), but only weakly respond to phasic activation of CINs (<xref ref-type="bibr" rid="bib29">English et al., 2011</xref>), we made targeted current-clamp recordings from PV-Cre × Ai9-tdTomato transgenic mice (<xref ref-type="bibr" rid="bib45">Johansson and Silberberg, 2020</xref>) and tested the effect of nAChR blockade on their excitability (<xref ref-type="fig" rid="fig7">Figure 7d</xref>). Indeed, blocking nAChRs by bath application of DHβE significantly hyperpolarized the resting membrane potential of PV-FSIs (<xref ref-type="fig" rid="fig7">Figure 7d–e</xref>) – this effect of nAChR blockade was not universally observed in other populations of GINs that are involved in feedforward inhibition, such as spontaneously firing SOM+ interneurons, in which mecamylamine had no effect on firing rate and actually depolarized the average membrane potential (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1</xref>). Thus, tonic activation of nAChRs depolarizes the resting membrane potential of PV-FSIs, continuously holding them closer to the AP threshold, and thereby priming them to transmit cortically driven feedforward inhibition more efficiently to SPNs. Interestingly, the dependence upon trailing ‘primed’ GIN input may explain why mecamylamine was capable of diminishing the amplitude of relatively slow rising EPSPs (<xref ref-type="fig" rid="fig1">Figure 1e</xref>) but not faster peaking excitatory postsynaptic currents (EPSCs) (<xref ref-type="fig" rid="fig2">Figure 2b</xref>).</p><fig-group><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Nicotinic acetylcholine receptor (nAChR) blockade hyperpolarizes parvalbumin-positive fast-spiking interneurons (PV-FSI) resting membrane potential and reduces the frequency of spontaneous inhibitory postsynaptic currents (sIPSCs) in striatal spiny projection neurons (SPNs).</title><p>(<bold>A</bold>) Example recordings of sIPSCs from SPNs voltage-clamped at +10 mV, before and during mecamylamine (10 µM) application. (<bold>B</bold>) Mecamylamine significantly enhanced sIPSC frequency in SPNs (F8,108=2.607, p=0.012; n=13; two-way ANOVA). A post hoc Bonferroni test revealed that this decrease was limited to low-amplitude sIPSCs (20 pA bin: p&lt;0.001; 25 pA bin: p&lt;0.01). (<bold>C</bold>) Mecamylamine caused a rightward shift in the cumulative probability distribution of sIPSC interevent intervals in SPNs (F(20,252)=2.10, p=4.7·10<sup>–3</sup>; n=13; two-way ANOVA). (<bold>D</bold>) Example traces of a PV-FSI before and after wash-in of 1 µM dihydro-β-erythroidine hydrobromide (DHβE). (<bold>E</bold>) Resting membrane potentials of PV-FSIs before and after wash-in of DHβE (n=12; p=9.8·10<sup>–4</sup>; signed-rank test [SRT]).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-75829-fig7-v2.tif"/></fig><fig id="fig7s1" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 1.</label><caption><title>Nicotinic acetylcholine receptor (nAChR) blockade depolarizes somatostatin (SOM)+ interneuron membrane potential.</title><p>(<bold>A</bold>) Example cell-attached recordings of a SOM+ interneuron before and after wash-in of mecamylamine (VC = 0 mV, artificial cerebrospinal fluid [ACSF] in recording electrode). (<bold>B</bold>) Firing rate calculated from cell-attached recordings before and after mecamylamine (n=5). (<bold>C</bold>) Example whole-cell recordings of a SOM+ interneuron before and after wash-in of mecamylamine. Action potential (AP) peaks truncated to highlight changes in average membrane potential. (<bold>D</bold>) Firing rate calculated from whole-cell recordings before and after mecamylamine (n=19, p=0.177, signed-rank test [SRT]). (<bold>E</bold>) Average membrane potential before and after wash-in of mecamylamine (n=17, p=4·10<sup>–4</sup>, SRT).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-75829-fig7-figsupp1-v2.tif"/></fig></fig-group><p>If SPN spike latency is perpetually slowed due to tonic nAChR-mediated ‘priming’ of presynaptic GINs, then taking the relevant GINs offline should mimic and occlude the effect of mecamylamine. Unlike some other GINs that target SPNs, such as persistent/plateau-low-threshold spiking (LTS) interneurons (<xref ref-type="bibr" rid="bib80">Tepper et al., 2010</xref>; <xref ref-type="bibr" rid="bib65">Plotkin and Goldberg, 2019</xref>), synaptic responses of PV-FSIs to cortical inputs are mediated by Ca<sup>2+</sup>-permeable AMPA receptors that lack the GluA2 subunit (<xref ref-type="bibr" rid="bib36">Gittis et al., 2010</xref>). In fact, pharmacological blockade of Ca<sup>2+</sup>-permeable GluA2-lacking AMPA receptor subunits prevents cortical activation of PV-FSIs but not persistent/plateau-LTS interneurons (<xref ref-type="bibr" rid="bib36">Gittis et al., 2010</xref>; <xref ref-type="bibr" rid="bib37">Gittis et al., 2011</xref>). Indeed, pharmacologically preventing cortical activation of PV-FSIs with the Ca<sup>2+</sup>-permeable AMPA receptor antagonist 1-naphthyl acetyl spermine (Naspm; 100 µM) not only reduced spike latency and ADP amplitude, but occluded the effect of mecamylamine (<xref ref-type="fig" rid="fig8">Figure 8</xref>). Taken together, these data demonstrate that tonic activation of nAChRs on a subclass of GINs is responsible for delaying cortically evoked SPN spiking, and implicate PV-FSIs as the primary mediator.</p><fig id="fig8" position="float"><label>Figure 8.</label><caption><title>Blockade of Ca<sup>2+</sup>-permeable AMPA receptors, to prevent cortical activation of parvalbumin-positive fast-spiking interneurons (PV-FSIs) and related GABAergic interneurons (GINs), mimics and occludes the effect of mecamylamine on striatal spiny projection neuron (SPN) spike latency.</title><p>(<bold>A</bold>) Example of the occlusion of the mecamylamine effect on optogenetic synaptic activation of SPNs by the Ca<sup>2+</sup>-permeable AMPA receptor antagonist 1-naphthyl acetyl spermine (Naspm) (100 µM). Distribution of spike latencies (<bold>B</bold>) and afterdepolarization (ADP) amplitude (<bold>C</bold>) in response to application of Naspm followed by mecamylamine show that Naspm significantly shortens the action potential (AP) latency (p=1.22·10<sup>–4</sup>, n=14 SPNs, signed-rank test [SRT]) and enhancement of the ADP amplitude (p=1.95·10<sup>–3</sup>, n=11 SPNs, SRT). In contrast, the subsequent mecamylamine application fails to further shorten the AP latency (p=0.6875, n=7 SPNs, SRT) or further enhance the ADP amplitude (p=0.625, n=4, SRT).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-75829-fig8-v2.tif"/></fig><p>In summary, the tonic activity of CINs recruits a subclass of GINs, namely PV-FSIs, to provide a ‘nicotinic brake’ on SPN responsiveness to cortical activity (<xref ref-type="fig" rid="fig9">Figure 9</xref>). Such a mechanism could allow SPNs to be more receptive of cortical inputs when CINs pause their firing in response to salient inputs or stimuli associated with reward.</p><fig id="fig9" position="float"><label>Figure 9.</label><caption><title>Proposed model of tonic nicotinic acetylcholine receptor (nAChR)-mediated suppression of cortically driven striatal spiny projection neuron (SPN) spike latency.</title><p>Example cholinergic interneuron (CIN) and SPN firing patterns shown below; dashed red arrows indicate diminished signaling during CIN pauses; Glu = glutamate.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-75829-fig9-v2.tif"/></fig></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>The present study describes a novel role for tonic nAChR activation in shaping striatal output. Decades of research have firmly established CINs as important modulators – mostly via mAChRs (<xref ref-type="bibr" rid="bib39">Goldberg et al., 2012</xref>; <xref ref-type="bibr" rid="bib90">Zucca et al., 2018</xref>; <xref ref-type="bibr" rid="bib14">Assous, 2021</xref>) – of cortico- and thalamo-striatal synaptic integration and determinants of striatal output (<xref ref-type="bibr" rid="bib5">Akins et al., 1990</xref>; <xref ref-type="bibr" rid="bib29">English et al., 2011</xref>; <xref ref-type="bibr" rid="bib2">Abudukeyoumu et al., 2019</xref>). Despite the fact that CINs are autonomous pacemakers, nearly all studies examining their influence on the precise temporal output of the striatum, particularly via nAChRs, have been centered around the consequences of their phasic engagement (<xref ref-type="bibr" rid="bib87">Witten et al., 2010</xref>; <xref ref-type="bibr" rid="bib29">English et al., 2011</xref>; <xref ref-type="bibr" rid="bib31">Faust et al., 2016</xref>; <xref ref-type="bibr" rid="bib26">Dorst et al., 2020</xref>). Here, we report that ongoing, non-phasic activation of nAChRs accounts for a basal elevation in GABAergic tone, which dampens the response of SPNs to convergent cortical inputs and ultimately delays striatal output.</p><sec id="s3-1"><title>Basal cholinergic regulation of striatal output – a postsynaptic ‘nicotinic brake’?</title><p>CINs can robustly evoke GABAergic inhibition in the striatum by engaging somatodendritic nAChRs on specific classes of local GINs, in particular those expressing NPY (<xref ref-type="bibr" rid="bib29">English et al., 2011</xref>; <xref ref-type="bibr" rid="bib52">Luo et al., 2013</xref>). This cell-type-specific nAChR-dependent mechanism has been demonstrated using electrical or optogenetic stimulation to drive <italic>phasic</italic>, stimulation-locked inhibition. Somewhat puzzling, however, are reports that certain GINs, including PV-FSIs, only weakly respond to phasic activation of CINs or cholinergic afferents from the midbrain (<xref ref-type="bibr" rid="bib23">Dautan et al., 2020</xref>) even though they express the requisite somatodendritic nAChRs (<xref ref-type="bibr" rid="bib48">Koós and Tepper, 2002</xref>; <xref ref-type="bibr" rid="bib29">English et al., 2011</xref>; <xref ref-type="bibr" rid="bib59">Nelson et al., 2014a</xref>; <xref ref-type="bibr" rid="bib60">Nelson et al., 2014b</xref>). Our finding that tonic activation of nAChRs enhances the excitability of FSIs, as has been shown previously (<xref ref-type="bibr" rid="bib48">Koós and Tepper, 2002</xref>; <xref ref-type="bibr" rid="bib52">Luo et al., 2013</xref>), offers a physiological role for these receptors. In fact, tonic activation of nAChRs on FSIs (driven by the tonic activity of CINs) may partly explain why previous studies have only observed modest responses of FSIs to additional phasic stimulation of CINs (<xref ref-type="bibr" rid="bib29">English et al., 2011</xref>; <xref ref-type="bibr" rid="bib59">Nelson et al., 2014a</xref>).</p><p>Tonic nAChR excitation of GINs helps clarify another puzzling observation. It is obvious why GABAR blockers occlude the effect of mecamylamine on AP latency and ADP amplitude in SPNs – the relevant GABARs are synaptically downstream of the nAChRs on GINs. But why is it that mecamylamine seems to ‘saturate’ the effect of GABAR inhibition on SPN AP latency and ADP? In other words, why does blockade of GABARs have no additional effect on AP latency or ADP when applied after mecamylamine, when phasic CIN activation only engages a select few types of GINs? If nAChRs were recruited solely by phasic activation of CINs, then the addition of GABAR blockers after mecamylamine should further shorten the AP latency and increase ADP amplitude by attenuating the influence of other GINs (such as PV-FSIs) that are only weakly responsive to phasic activation of nAChRs (<xref ref-type="bibr" rid="bib29">English et al., 2011</xref>; <xref ref-type="bibr" rid="bib59">Nelson et al., 2014a</xref>; <xref ref-type="bibr" rid="bib60">Nelson et al., 2014b</xref>). A ‘priming’ effect of tonic nAChR activation on GINs that are not directly driven to spike by CINs could explain the seemingly oversized influence of nicotinic signaling on GABAergic inhibition. It is also worth noting that such ‘priming’ of feed forward inhibition (where SPNs and GINs are activated near-simultaneously by converging corticostriatal afferents) will ensure that this effect of GINs on SPNs is always inhibitory, despite the relatively depolarized reversal potential of Cl<sup>-</sup> in SPNs in vivo (<xref ref-type="bibr" rid="bib16">Bracci and Panzeri, 2006</xref>), particularly when SPNs are at a near threshold membrane voltage (<xref ref-type="fig" rid="fig1">Figure 1F,G</xref>).</p><p>While an exhaustive categorization of the role every GIN class plays (or does not play) in mediating the observed effect may be ill-posed, we have identified PV-FSIs as the likely primary contributor. First, blockade of nAChRs hyperpolarized PV-FSIs at rest, suggesting that tonic activation of nAChRs holds these GINs closer to spike threshold. We observed the opposite effect in a similar class of GINs that mediates feedforward inhibition (SOM+ interneurons), making their involvement in the process less likely. While the effect on PV-FSI resting membrane potential that we observed was modest, we note that a similar magnitude mecamylamine-induced hyperpolarization is sufficient to slow the spontaneous firing rate of NPY-expressing LTS interneurons (<xref ref-type="bibr" rid="bib28">Elghaba et al., 2016</xref>). Second, pharmacologically blocking cortical activation of PV-FSIs with a Ca<sup>2+</sup>-permeable AMPA receptor antagonist, which leaves synaptic activation of other GINs such as persistent/plateau-LTS interneurons intact, completely occluded the effect of mecamylamine on SPN spike latency. Together, these data corroborate PV-FSIs as the primary candidate to exert the ‘nicotinic brake’ we observed during basal circuit activity.</p></sec><sec id="s3-2"><title>Under what conditions will the ‘nicotinic brake’ be lifted?</title><p>Through their continuous autonomous discharge, CINs tonically release ACh in the striatum (<xref ref-type="bibr" rid="bib89">Zhou et al., 2002</xref>). While a prolonged exposure of striatal nAChRs to ACh is bound to desensitize them, it has been argued that the fast action of striatal acetylcholinesterase (AChE) prevents nAChR desensitization, allowing for the maintenance of tonic nAChR activation in the striatum (<xref ref-type="bibr" rid="bib89">Zhou et al., 2002</xref>). So if tonic nAChR activation normally puts a brake on cortical feedforward inhibition, under what circumstances is this brake removed? The TANs of the primate striatum, which are comprised mainly of CINs (<xref ref-type="bibr" rid="bib86">Wilson et al., 1990</xref>; <xref ref-type="bibr" rid="bib8">Aosaki et al., 1995</xref>), acquire a synchronized pause response (<xref ref-type="bibr" rid="bib68">Raz et al., 1996</xref>) in their tonic firing that lasts several hundred milliseconds in response to primary reward or, through conditioning, to salient stimuli associated with reward (<xref ref-type="bibr" rid="bib46">Kimura et al., 1984</xref>; <xref ref-type="bibr" rid="bib9">Apicella et al., 1997</xref>; <xref ref-type="bibr" rid="bib38">Goldberg and Reynolds, 2011</xref>; <xref ref-type="bibr" rid="bib17">Bradfield et al., 2013</xref>). This pause duration should be sufficient – particularly while AChE rapidly clears the extracellular space from ACh – to deactivate the nAChRs, thereby removing the nicotinic brake.</p><p>Our study complements a recent study that described how CINs impact SPN neural dynamics in vivo (<xref ref-type="bibr" rid="bib90">Zucca et al., 2018</xref>). In that study it was shown that when CINs are optogenetically silenced in a synchronous fashion for a sufficiently long period, SPNs become hyperpolarized, less excitable, and short-term corticostriatal plasticity is dampened. However, these effects commence only 400 ms after CINs are silenced. Until that point SPN excitability is unaffected. Thus, that study remained agnostic about the effect of CIN pauses that are shorter than 400 ms long on SPNs. Because physiological TAN pauses in response to sensory cues are typically over after 300 ms (<xref ref-type="bibr" rid="bib46">Kimura et al., 1984</xref>; <xref ref-type="bibr" rid="bib9">Apicella et al., 1997</xref>), the mAChR-mediated curbing of SPN excitability and responsiveness revealed in that and other studies (<xref ref-type="bibr" rid="bib27">Ebihara et al., 2013</xref>) may not be relevant to the role of the shorter, more physiological CIN pauses. Assuming that the nAChR-dependent mechanism we revealed can come into play sooner, our findings suggest that there are two dichotomous phases to the effect of synchronous CIN pauses: an ‘early’ period that is dominated by the consequences of removing tonic nAChR activation, and a more delayed period driven by diminished activation of mAChRs, where the responsiveness of SPNs to incoming cortical input is weakened, as shown previously (<xref ref-type="bibr" rid="bib90">Zucca et al., 2018</xref>).</p></sec><sec id="s3-3"><title>Implications for tuning striatal circuit activity</title><p>Our data suggest that as CIN pauses develop ongoing GABAergic inhibition will be relieved. This could have the effect of sharpening the timing of cortically driven spiking by several milliseconds, ultimately shaping the moment-by-moment processing of striatal output. Because the TAN pause usually coincides with the arrival of a salient stimulus, it is precisely a moment when SPNs need to be more attuned to cortical input and respond more reliably. Given the relatively higher affinity of α4β2 vs. α7 nAChRs (<xref ref-type="bibr" rid="bib6">Albuquerque et al., 2009</xref>), it is not surprising that we found α7-mediated boosting of presynaptic glutamate release to be insensitive to tonic ACh levels, setting the stage for a CIN pause-initiated drop in ACh levels to promote a temporal sharpening of any proceeding SPN spikes that are induced. Moreover, seminal experiments in primates have shown that CIN pauses become more prominently and reliably evoked by sensory stimuli over the course of Pavlovian conditioning (<xref ref-type="bibr" rid="bib7">Aosaki et al., 1994</xref>; <xref ref-type="bibr" rid="bib8">Aosaki et al., 1995</xref>). Together, this implies that removal of the ‘nicotinic brake’ may be a crucial component of striatal learning. While a several milliseconds shift in spike timing may not seem like much in the context of 100 s of milliseconds long CIN pauses or SPN state transitions, it may be ample time to move a spike into or out of the time window for NMDA receptor-dependent coincidence detection to occur (<xref ref-type="bibr" rid="bib42">Hao and Oertner, 2012</xref>).</p><p>Both dSPNs and iSPNs robustly support spike timing-dependent plasticity (<xref ref-type="bibr" rid="bib63">Pawlak and Kerr, 2008</xref>; <xref ref-type="bibr" rid="bib72">Shen et al., 2008</xref>). Under permissive conditions, constraining the relative timing of SPN APs to occur 5 ms after a corticostriatal synaptic burst efficiently potentiates the active synapses (<xref ref-type="bibr" rid="bib72">Shen et al., 2008</xref>). In this view, decreasing the time to spike on the time scale we observe may be sufficient to bring the spike temporally close enough to NMDA receptor activation to engage the signaling cascades that are crucial for long-term potentiation. Such subtle nAChR-dependent tuning could be a way of ‘distancing’ those same cortical afferents from SPN activity under conditions of basal activity, allowing for the synapses encoding a particular sensorimotor cue to become potentiated only when deemed appropriate by a learned cholinergic signal. Expanding upon this possibility, it was recently shown that synapse-specific corticostriatal long-term potentiation requires the coordination of CIN pauses with DA release and SPN depolarization (<xref ref-type="bibr" rid="bib69">Reynolds et al., 2022</xref>). It is tempting to speculate that a function of the CIN pause in the scenario is to create a window of plasticity by removing the ‘nicotinic brake’ to reduce synaptic inhibition and promote and adjust the latency of evoked spikes.</p><p>The extent to which tonic activation of nAChRs will be capable of influencing GABA release and SPN responses to cortical inputs will likely depend on the capacity of AChE activity to both allow for the detection of a CIN pause and minimize nAChR desensitization (<xref ref-type="bibr" rid="bib89">Zhou et al., 2002</xref>). This brings up an important corollary of the ‘nicotinic brake’ hypothesis: the putative mechanism by which CIN pauses remove the nicotinic brake may be most robust in the AChE-enriched compartment of the striatum, also known as the matrix (as opposed to striosomes) (<xref ref-type="bibr" rid="bib40">Graybiel and Ragsdale, 1978</xref>; <xref ref-type="bibr" rid="bib18">Brimblecombe and Cragg, 2017</xref>; <xref ref-type="bibr" rid="bib67">Prager and Plotkin, 2019</xref>). Because the matrix constitutes ~85% of the striatum, our data likely reflect the situation in that compartment (<xref ref-type="bibr" rid="bib67">Prager and Plotkin, 2019</xref>). While coordinated CIN activation can interrupt the timing of ongoing APs in both matrix and striosome SPNs (<xref ref-type="bibr" rid="bib22">Crittenden et al., 2017</xref>), the degree of tonic nAChR activation and existence of a ‘nicotinic brake’ in striosomes is unclear.</p><p>Taken together, our data suggest an additional role for cholinergic signaling in shaping striatal activity. While a great deal is known about how ACh can impact SPN function through metabotropic muscarinic receptors, nearly all studies of the ‘faster’ nAChR arm of ACh signaling have focused on its phasic activation. The data in this study demonstrate that nAChR signaling is not constrained to times of phasic CIN engagement, and tonic activation of nAChRs places a ‘brake’ on SPN activity that may help guide the fine tuning of striatal output.</p></sec></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Strain, strain background (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">C57BL/6J</td><td align="left" valign="bottom">Jackson Laboratory</td><td align="left" valign="bottom">RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_JAX:000664">IMSR_JAX:000664</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">B6.FVB-Tg(<italic>Drd2</italic>-EGFP/Rpl10a)CP101Htz/J</td><td align="left" valign="bottom">Jackson Laboratory</td><td align="left" valign="bottom">RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_JAX:030255">IMSR_JAX:030255</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">B6.Cg-Tg(<italic>Drd1a</italic>-tdTomato)6Calak/J</td><td align="left" valign="bottom">Jackson Laboratory</td><td align="left" valign="bottom">RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_JAX:016204">IMSR_JAX:016204</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">B6.Cg-Tg(<italic>Thy1</italic>-COP4/EYFP)18Gfng/J</td><td align="left" valign="bottom">Jackson Laboratory</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_JAX:007612">IMSR_JAX:007612</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom"><italic>Pvalb</italic>-cre</td><td align="left" valign="bottom">Jackson Laboratory</td><td align="left" valign="bottom">RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_JAX:017320">IMSR_JAX:017320</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom"><italic>Sst</italic>-cre</td><td align="left" valign="bottom">Jackson Laboratory</td><td align="left" valign="bottom">RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_JAX:018973">IMSR_JAX:018973</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">Ai9 (‘tdTomato’)</td><td align="left" valign="bottom">Jackson Laboratory</td><td align="left" valign="bottom">RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_JAX:007909">IMSR_JAX:007909</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">AAV5-Ef1a-DIO-EYFP</td><td align="left" valign="bottom">Addgene</td><td align="char" char="hyphen" valign="bottom">27056-AAV5</td><td align="left" valign="bottom"><italic>Adeno-associated virus</italic> (AAV)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Mecamylamine hydrochloride</td><td align="left" valign="bottom">Sigma-Aldrich<break/>Tocris</td><td align="left" valign="bottom">Lot # 019M4108V<break/>CAS: 826-39-1<break/>#2843, CAS: 110691-49-1</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Dihydro-β-erythroidine hydrobromide</td><td align="left" valign="bottom">Tocris</td><td align="left" valign="bottom">#2349, CAS: 29734-68-7</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">SR 95531 hydrobromide (Gabazine)</td><td align="left" valign="bottom">Hello Bio</td><td align="left" valign="bottom">CAS:<break/>104104-50-9</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">DNQX</td><td align="left" valign="bottom">TOCRIS</td><td align="left" valign="bottom">CAS:<break/>2379-57-9</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">D-AP5</td><td align="left" valign="bottom">Hello Bio</td><td align="left" valign="bottom">CAS:79055-68-8</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Methyllycaconitine citrate</td><td align="left" valign="bottom">TOCRIS</td><td align="left" valign="bottom">Lot # 23A/255947<break/>CAS:351344-10-0</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Naspm trihydrochloride</td><td align="left" valign="bottom">Alomone Labs</td><td align="left" valign="bottom">CAS: 1049731-36-3</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">CGP 55845 hydrochloride</td><td align="left" valign="bottom">Hello Bio</td><td align="left" valign="bottom">CAS: 149184-22-5</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">XYLAZINE AS HYDROCHLORIDE</td><td align="left" valign="bottom">EUROVET ANIMAL HEALTH B.V</td><td align="left" valign="bottom">CAS: 082-91-92341-00</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">CLORKETAM</td><td align="left" valign="bottom">VETOQUINOL</td><td align="left" valign="bottom">CAS: 1867-66-9</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">VECTASHIELD Vibrance Antifade Mounting Medium with DAPI</td><td align="left" valign="bottom">VECTOR LABORATORIES</td><td align="left" valign="bottom">SKU: H-1800</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Recombinant Anti-GAD65+GAD67 antibody [EPR19366]</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">ab183999</td><td align="left" valign="bottom">Rabbit monoclonal<break/>(1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Rabbit polyclonal anti Somatostatin-14</td><td align="left" valign="bottom">Peninsula Laboratories</td><td align="left" valign="bottom">T-4102</td><td align="left" valign="bottom">Rabbit polyclonal<break/>(1:100)</td></tr></tbody></table></table-wrap><sec id="s4-1"><title>Animals</title><p>All experimental procedures on mice adhered to and received prior written approval from the Institutional Animal Care and Use Committees of the Hebrew University of Jerusalem (MD-14-14195-3 and MD-18-15657-3) and of Stony Brook University (737496) and of the local ethics committee of Stockholm, Stockholms Norra djurförsöksetiska nämnd (N2022_2020). Experiments were conducted on various transgenic mice. For optogenetic activation of corticostriatal fibers, we used 1- to 4-month-old male and female homozygous transgenic <italic>Thy1</italic>-ChR2 mice (B6.Cg-Tg(Thy1-COP4/EYFP)18Gfng/J) that express ChR2 under the <italic>Thy1</italic> promoter were used. <italic>Thy1</italic>-ChR2 mice express ChR2 in cortical afferents under the thymus cell antigen 1 (<italic>Thy1</italic>) promoter. <italic>Thy1</italic> is generally expressed in the axons of layer V pyramidal neurons, limbic system, midbrain, and brainstem (<xref ref-type="bibr" rid="bib11">Arenkiel et al., 2007</xref>). For experiments measuring paired pulse ratios (PPRs), neuronal excitability and spontaneous GABAergic events, we used 1.5- to 4-month-old male and female C57BL/6 mice crossed with one of two BAC transgenic lines (where indicated): <italic>drd1a</italic>-tdTomato (labeling dSPNs) or <italic>drd2</italic>-eGFP (labeling iSPNs) (<xref ref-type="bibr" rid="bib73">Shuen et al., 2008</xref>; <xref ref-type="bibr" rid="bib4">Ade et al., 2011</xref>). For PV-FSI and SOM+ interneuron recordings, both male and female mice (postnatal days 47–82) were used in this study. Mice were group-housed under a 12 hr light/dark schedule and given ad libitum access to food and water. The <italic>Pvalb</italic>-Cre (stock #017320, the Jackson laboratory) mouse line was crossed with a homozygous tdTomato reporter mouse line (‘Ai9’, stock #007909, the Jackson laboratory) to allow identification of FSIs based on the expression of a fluorescent marker protein. SOM+ interneurons were identified by injecting cre-dependent AAV (27056-AAV5, Addgene) into the striatum of <italic>Sst</italic>-cre mice, inducing the expression of YFP in SOM-positive neurons specifically (stock #018973, the Jackson Laboratory). The PV- and SOM- Cre lines were heterozygous and maintained on a wild-type C57BL/6J background (stock # 000664, the Jackson Laboratory).</p></sec><sec id="s4-2"><title>Virus injections</title><p>SOM- cre mice were anesthetized with isoflurane and placed in a stereotaxic frame (Harvard Apparatus, Holliston, MA). A Quintessential Stereotaxic Injector (Stoelting, Wood Dale, IL) was used to inject 0.5 µl of AAV5-EF1a-DIO-EYFP (#27056, Addgene) into the striatum (+0.5 AP, 2 ML, 2.5 DV) at a speed of 0.1 µl/min. The pipette was held in place for at least 5 min after the injection. Following the surgery, the mice were given analgesics (buprenorphine, 0.08 mg/kg, i.p.).</p></sec><sec id="s4-3"><title>Slice preparation</title><p>For optogenetic activation experiments, PPR, excitability and spontaneous GABAergic event experiments: Mice were deeply anesthetized with ketamine-xylazine and perfused transcardially with ice-cold modified artificial cerebrospinal fluid (ACSF) bubbled with 95% O<sub>2</sub>–5% CO<sub>2</sub>, and containing (in mM): 2.5 KCl, 26 NaHCO<sub>3</sub>, 1.25 Na<sub>2</sub>HPO<sub>4</sub>, 0.5 CaCl<sub>2</sub>, 10 MgSO<sub>4</sub>, 0.4 ascorbic acid, 10 glucose, and 210 sucrose (optogenetic activation studies) or 3 KCl, 26 NaHCO<sub>3</sub>, 1 NaH<sub>2</sub>PO<sub>4</sub>, 1 CaCl<sub>2</sub>, 1.5 MgCl<sub>2</sub>, 124 NaCl, and 14 glucose (PPR, excitability and spontaneous GABAergic event measures). The brain was removed and sagittal or coronal slices sectioned at a thickness of 275 µm were obtained in ice-cold modified ACSF. Slices were then submerged in ACSF, bubbled with 95% O<sub>2</sub>–5% CO<sub>2</sub>, and containing (in mM): 2.5 KCl, 126 NaCl, 26 NaHCO<sub>3</sub>, 1.25 Na<sub>2</sub>HPO<sub>4</sub>, 2 CaCl<sub>2</sub>, 2 MgSO<sub>4</sub>, and 10 glucose and stored at room temperature for at least 1 hr prior to recording (optogenetic activation studies), or 3 KCl, 26 NaHCO<sub>3</sub>, 1 NaH<sub>2</sub>PO<sub>4</sub>, 2 CaCl<sub>2</sub>, 1 MgCl<sub>2</sub>, 124 NaCl, and 14 glucose, incubated at 32°C for 45 min, then held at room temperature until recording (PPR, excitability and spontaneous GABAergic event measures).</p><p>For PV-FSI and SOM+ experiments: Mice were deeply anesthetized with isoflurane and decapitated. The brain was removed and immersed in ice-cold cutting solution containing 205 mM sucrose, 10 mM glucose, 25 mM NaHCO<sub>3</sub>, 2.5 mM KCl, 1.25 mM NaH2PO<sub>4</sub>, 0.5 mM CaCl<sub>2</sub>, and 7.5 mM MgCl<sub>2</sub>. Parasagittal brain slices (thickness 250 mm) were prepared with a Leica VT1000S vibratome and incubated for 30–60 min at 34°C in a submerged chamber filled with ACSF saturated with 95% oxygen and 5% carbon dioxide. ACSF was composed of 125 mM NaCl, 25 mM glucose, 25 mM NaHCO<sub>3</sub>, 2.5 mM KCl, 2 mM CaCl<sub>2</sub>, 1.25 mM NaH<sub>2</sub>PO<sub>4</sub>, 1 mM MgCl<sub>2</sub>. Subsequently, slices were kept for at least 30 min at room temperature before recording.</p></sec><sec id="s4-4"><title>Slice visualization, electrophysiology, and optogenetic stimulation</title><p>For optogenetic activation experiments: The slices were transferred to the recording chamber mounted on an Olympus BX51 upright, fixed-stage microscope and perfused with oxygenated ACSF at room temperature. A 60×, 0.9 NA water immersion objective was used to examine the slice using Dodt contrast video microscopy. Patch pipette resistance was typically 3–4 MΩ when filled with recording solutions. In voltage-clamp experiments of IPSCs in SPNs, the intracellular solution contained (in mM): 127.5 CsCH<sub>3</sub>SO<sub>3</sub>, 7.5 CsCl, 10 HEPES, 10 TEA-Cl, 4 phosphocreatine disodium, 0.2 EGTA, 0.21 Na<sub>2</sub>GTP, and 2 Mg<sub>1.5</sub>ATP (pH = 7.3 with CsOH, 280–290 mOsm/kg). For whole-cell current-clamp recordings from SPNs and cell-attached recordings from CINs, the pipette contained (in mM): 135.5 KCH<sub>3</sub>SO<sub>4</sub>, 5 KCl, 2.5 NaCl, 5 Na-phosphocreatine, 10 HEPES, 0.2 EGTA, 0.21 Na<sub>2</sub>GTP, and 2 Mg<sub>1.5</sub>ATP (pH = 7.3 with KOH, 280–290 mOsm/kg). Electrophysiological recordings were obtained with a Multiclamp 700B amplifier (Molecular Devices, Sunnyvale, CA). Junction potential, which was 7–8 mV, was not corrected. Signals were digitized at 10 kHz and logged onto a personal computer with the Winfluor software (John Dempster, University of Strathclyde, UK). Blue light LED (470 nm, Mightex, Toronto, Ontario, Canada) was used for full-field illumination via the objective. Single pulses were 1 ms long. In order to compare AP latency and ADP amplitude among SPNs, the LED intensity was set to generate a just suprathreshold response in each SPN recorded.</p><p>For PPR, excitability and spontaneous GABAergic event experiments: The slices were transferred to the recording chamber mounted on a modified Ultima laser scanning microscope system (Bruker Nano) (excitability and spontaneous GABAergic event experiments) or an Olympus BX51W1 microscope (PPR experiments) and perfused with oxygenated ACSF at room temperature. A 60×, 1.0 NA Olympus LUMPFL water immersion objective was used to visualize slices, and fluorescently labeled neurons identified for recordings with the aid of a Dodt contrast image displayed in registration with the fluorescence image for experiments requiring identification of dSPNs vs. iSPNs. Patch pipette resistance was typically 3–6 MΩ when filled with recording solutions. For voltage-clamp recordings, the intracellular solution contained (in mM): 120 CsMeSO<sub>3</sub>, 5 NaCl, 10 TEA-Cl (tetraethylammonium-Cl), 10 HEPES, 5 Qx-314, 4 ATP-Mg<sup>2+</sup>, 0.3 GTP-Na<sup>+</sup>, 0.25 EGTA, and 0.05 Alexa Fluor 568 hydrazide Na<sup>+</sup>salt (Alexa Fluor was omitted in PPR experiments). For current-clamp recordings, the internal solution contained (in mM): 135 KMeSO<sub>4</sub>, 5 KCl, 10 HEPES, 2 ATP-Mg<sup>2+</sup>, 0.5 GTP-Na<sup>+</sup>, 5 phosphocreatine-tris, 5 phosphocreatine-Na<sup>+</sup>, 0.1 Fluo-4 pentapotassium salt, and 0.05 Alexa Fluor 568 hydrazide Na<sup>+</sup> salt. Patched SPNs were allowed to equilibrate for 10 min after rupture. Recordings were made using a Multiclamp 700B amplifier and either PrairieView 5.0 software (Bruker) or custom MATLAB protocols. sIPSCs were recorded in voltage-clamp mode at +10 mV for 180 s before and after bath application of drug. Access resistance and holding current were monitored throughout experiments and cells were excluded if these values changed by more than 20%. Local electrical stimulation was evoked using a concentric bipolar stimulation electrode (FHC, Inc, Bowdoin, ME) placed near the cell using a stimulating amplitude of ~1–3 mV and 50 ms between stimuli pulses; 10 sweeps (10 s intersweep interval) were averaged per cell; cells were held at –70 mV. PPR experiments were performed at 26–29°C. Rheobase and AP firing frequencies were determined in current-clamp mode via a step series of 500 ms current injections starting at –200 pA and increasing by 25 pA with each step. Resting membrane potential and cell morphology were monitored throughout experiments and cells were excluded if resting at a more depolarized potential than –77.0 mV.</p><p>For PV-FSI and SOM+ experiments: Whole-cell patch clamp recordings were obtained in oxygenated ACSF at 35°C. Neurons were visualized using infrared differential interference contrast microscopy (Zeiss FS Axioskop, Oberkochen, Germany). tdTomato- or EYFP-expressing neurons were identified by switching to epifluorescence using a mercury lamp (X-cite, 120Q, Lumen Dynamics). Borosilicate pipettes of 5–8 MOhm resistance were pulled with a Flaming/Brown micropipette puller P-1000 (Sutter instruments). All recordings were done in current clamp with an intracellular solution containing 130 mM K-gluconate, 5 mM KCl, 10 mM HEPES, 4 mM Mg-ATP, 0.3 mM GTP, 10 mM Na<sub>2</sub>-phospho-creatine (pH 7.25, osmolarity 285 mOsm). Recordings were amplified using a MultiClamp 700B amplifier (Molecular Devices, San Jose, CA), filtered at 2 kHz, digitized at 10–20 kHz using ITC-18 (HEKA Elektronik GmbH, Germany), and acquired using custom-made routines running on Igor Pro (Wavemetrics, Portland, OR). Liquid junction potential was not corrected. Throughout all recordings, pipette capacitance and access resistance were compensated for and data were discarded when access resistance increased beyond 30 MOhm. The intrinsic properties of the neurons were determined by a series of hyperpolarizing and depolarizing current steps and ramps, enabling the extraction of sub- and suprathreshold properties. All neurons were recorded in control conditions and after &gt;5 min of bath application of 1 µM DHβE (Tocris) or 10 µM Mec (Tocris).</p></sec><sec id="s4-5"><title>Drugs and reagents</title><p>Experiments in Thy1-ChR2 mice were performed in the presence or absence of synaptic receptor blockers including 10 µM SR-95531 (gabazine) to block GABA<sub>A</sub> receptors, 2 µM CGP-55845 to block GABA<sub>B</sub> receptors, 10 µM mecamylamine, a non-selective nAChR-antagonist, 1 or 10 µM DHβE, a competitive α4β2 nAChR antagonist and Naspm (100 µM), a Ca<sup>2+</sup>-permeable AMPA receptor antagonist. Experiments were conducted with various combinations of the blockers. The acute effects of solution exchanges were measured at least 5 min after wash on. All drugs and reagents were acquired from Tocris (Ellisville, MO), Sigma (St Louis, MO) or HelloBio (Bristol, Avonmouth, UK).</p></sec><sec id="s4-6"><title>Histology</title><p>Nine-week-old female mice were deeply anesthetized with ketamine-xylazine followed by cold perfusion to the heart of PBS and 4% PFA. The removed brain was kept overnight at 4°C in 4%–4% PFA. The next day, the brain was washed in PBS (three times, 20 min each) before thin 40 µm coronal slices were made using a vibratome (Leica VT1000S). Slices were briefly washed with CAS-BLOCK (Life Technologies) before being incubated in CAS-BLOCK (300 µl) overnight with GAD65+67 antibodies (ab183999 Abcam, 1:1000) or Somatostatin (BMA Biomedicals Peninsula Laboratories T-4102, 1:100). The slices were then washed in PBS (three times, 20 min each) and incubated with CAS-BLOCK and secondary antibodies (Abcam ab150063, 1:500) for 3 hr. Antifade Mounting Medium (VECTASHIELD) was applied to prevent slice bleaching.</p></sec><sec id="s4-7"><title>Data analysis and statistics</title><p>Data analysis was performed using custom-made code in MATLAB (MathWorks, Natick, MA) or Python; sIPSCs were analyzed using the Mini Analysis program (Synaptosoft). Two-tailed Wilcoxon SRT was used to test for changes of medians in matched-paired comparisons. The null hypotheses were rejected if the p values were below 0.05. Boxplots represent range (whiskers), median (thick bar), and lower and upper quartiles. To analyze responses to stimulation, peristimulus time histograms (PSTHs) were generated. PSTHs were estimated using 20 ms wide bins. IV relationships, sIPSC frequencies, and interevent intervals were analyzed by two-way ANOVA.</p></sec></sec></body><back><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Formal analysis, Investigation</p></fn><fn fn-type="con" id="con2"><p>Formal analysis, Investigation</p></fn><fn fn-type="con" id="con3"><p>Formal analysis, Investigation</p></fn><fn fn-type="con" id="con4"><p>Formal analysis, Investigation</p></fn><fn fn-type="con" id="con5"><p>Formal analysis, Investigation</p></fn><fn fn-type="con" id="con6"><p>Conceptualization, Funding acquisition, Project administration, Supervision, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con7"><p>Conceptualization, Funding acquisition, Project administration, Supervision, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con8"><p>Conceptualization, Funding acquisition, Project administration, Supervision, Writing - original draft, Writing - review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>All experimental procedures on mice adhered to and received prior written approval from the Institutional Animal Care and Use Committees of the Hebrew University of Jerusalem (MD-14-14195-3 and MD-18-15657-3) and of Stony Brook University (737496) and of the local ethics committee of Stockholm, Stockholms Norra djurförsöksetiska nämnd (N2022_2020).</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-75829-transrepform1-v2.docx"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>All analyzed data sets, whether included in figures or referenced as 'not shown', have been uploaded to OSF and made publically available: <ext-link ext-link-type="uri" xlink:href="https://osf.io/7kazd">https://osf.io/7kazd</ext-link>.</p><p>The following dataset was generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Plotkin</surname><given-names>JL</given-names></name><name><surname>Goldberg</surname><given-names>J</given-names></name><name><surname>Silberberg</surname><given-names>G</given-names></name></person-group><source>Open Science Framework</source><year iso-8601-date="2022">2022</year><data-title>Matityahu et al</data-title><pub-id pub-id-type="accession" xlink:href="https://osf.io/7kazd">7kazd</pub-id></element-citation></p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abbondanza</surname><given-names>A</given-names></name><name><surname>Ribeiro Bas</surname><given-names>I</given-names></name><name><surname>Modrak</surname><given-names>M</given-names></name><name><surname>Capek</surname><given-names>M</given-names></name><name><surname>Minich</surname><given-names>J</given-names></name><name><surname>Tyshkevich</surname><given-names>A</given-names></name><name><surname>Naser</surname><given-names>S</given-names></name><name><surname>Rangotis</surname><given-names>R</given-names></name><name><surname>Houdek</surname><given-names>P</given-names></name><name><surname>Sumova</surname><given-names>A</given-names></name><name><surname>Dumas</surname><given-names>S</given-names></name><name><surname>Bernard</surname><given-names>V</given-names></name><name><surname>Janickova</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Nicotinic Acetylcholine Receptors Expressed by Striatal Interneurons Inhibit Striatal Activity and Control Striatal-Dependent Behaviors</article-title><source>The Journal of Neuroscience</source><volume>42</volume><fpage>2786</fpage><lpage>2803</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1627-21.2022</pub-id><pub-id pub-id-type="pmid">35165173</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abudukeyoumu</surname><given-names>N</given-names></name><name><surname>Hernandez-Flores</surname><given-names>T</given-names></name><name><surname>Garcia-Munoz</surname><given-names>M</given-names></name><name><surname>Arbuthnott</surname><given-names>GW</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Cholinergic modulation of striatal microcircuits</article-title><source>The European Journal of Neuroscience</source><volume>49</volume><fpage>604</fpage><lpage>622</lpage><pub-id pub-id-type="doi">10.1111/ejn.13949</pub-id><pub-id pub-id-type="pmid">29797362</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aceves Buendia</surname><given-names>JDJ</given-names></name><name><surname>Tiroshi</surname><given-names>L</given-names></name><name><surname>Chiu</surname><given-names>WH</given-names></name><name><surname>Goldberg</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Selective remodeling of glutamatergic transmission to striatal cholinergic interneurons after dopamine depletion</article-title><source>The European Journal of Neuroscience</source><volume>49</volume><fpage>824</fpage><lpage>833</lpage><pub-id pub-id-type="doi">10.1111/ejn.13715</pub-id><pub-id pub-id-type="pmid">28922504</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ade</surname><given-names>KK</given-names></name><name><surname>Wan</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>Gloss</surname><given-names>B</given-names></name><name><surname>Calakos</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>An Improved BAC Transgenic Fluorescent Reporter Line for Sensitive and Specific Identification of Striatonigral Medium Spiny Neurons</article-title><source>Frontiers in Systems Neuroscience</source><volume>5</volume><elocation-id>32</elocation-id><pub-id pub-id-type="doi">10.3389/fnsys.2011.00032</pub-id><pub-id pub-id-type="pmid">21713123</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akins</surname><given-names>PT</given-names></name><name><surname>Surmeier</surname><given-names>DJ</given-names></name><name><surname>Kitai</surname><given-names>ST</given-names></name></person-group><year iso-8601-date="1990">1990</year><article-title>Muscarinic modulation of a transient K+ conductance in rat neostriatal neurons</article-title><source>Nature</source><volume>344</volume><fpage>240</fpage><lpage>242</lpage><pub-id pub-id-type="doi">10.1038/344240a0</pub-id><pub-id pub-id-type="pmid">2314459</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Albuquerque</surname><given-names>EX</given-names></name><name><surname>Pereira</surname><given-names>EFR</given-names></name><name><surname>Alkondon</surname><given-names>M</given-names></name><name><surname>Rogers</surname><given-names>SW</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Mammalian nicotinic acetylcholine receptors: from structure to function</article-title><source>Physiological Reviews</source><volume>89</volume><fpage>73</fpage><lpage>120</lpage><pub-id pub-id-type="doi">10.1152/physrev.00015.2008</pub-id><pub-id pub-id-type="pmid">19126755</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aosaki</surname><given-names>T</given-names></name><name><surname>Tsubokawa</surname><given-names>H</given-names></name><name><surname>Ishida</surname><given-names>A</given-names></name><name><surname>Watanabe</surname><given-names>K</given-names></name><name><surname>Graybiel</surname><given-names>AM</given-names></name><name><surname>Kimura</surname><given-names>M</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Responses of tonically active neurons in the primate’s striatum undergo systematic changes during behavioral sensorimotor conditioning</article-title><source>The Journal of Neuroscience</source><volume>14</volume><fpage>3969</fpage><lpage>3984</lpage><pub-id pub-id-type="pmid">8207500</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aosaki</surname><given-names>T</given-names></name><name><surname>Kimura</surname><given-names>M</given-names></name><name><surname>Graybiel</surname><given-names>AM</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Temporal and spatial characteristics of tonically active neurons of the primate’s striatum</article-title><source>Journal of Neurophysiology</source><volume>73</volume><fpage>1234</fpage><lpage>1252</lpage><pub-id pub-id-type="doi">10.1152/jn.1995.73.3.1234</pub-id><pub-id pub-id-type="pmid">7608768</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Apicella</surname><given-names>P</given-names></name><name><surname>Legallet</surname><given-names>E</given-names></name><name><surname>Trouche</surname><given-names>E</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Responses of tonically discharging neurons in the monkey striatum to primary rewards delivered during different behavioral states</article-title><source>Experimental Brain Research</source><volume>116</volume><fpage>456</fpage><lpage>466</lpage><pub-id pub-id-type="doi">10.1007/pl00005773</pub-id><pub-id pub-id-type="pmid">9372294</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Apicella</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The role of the intrinsic cholinergic system of the striatum: What have we learned from TAN recordings in behaving animals?</article-title><source>Neuroscience</source><volume>360</volume><fpage>81</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1016/j.neuroscience.2017.07.060</pub-id><pub-id pub-id-type="pmid">28768155</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arenkiel</surname><given-names>BR</given-names></name><name><surname>Peca</surname><given-names>J</given-names></name><name><surname>Davison</surname><given-names>IG</given-names></name><name><surname>Feliciano</surname><given-names>C</given-names></name><name><surname>Deisseroth</surname><given-names>K</given-names></name><name><surname>Augustine</surname><given-names>GJ</given-names></name><name><surname>Ehlers</surname><given-names>MD</given-names></name><name><surname>Feng</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>In vivo light-induced activation of neural circuitry in transgenic mice expressing channelrhodopsin-2</article-title><source>Neuron</source><volume>54</volume><fpage>205</fpage><lpage>218</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2007.03.005</pub-id><pub-id pub-id-type="pmid">17442243</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Assous</surname><given-names>M</given-names></name><name><surname>Kaminer</surname><given-names>J</given-names></name><name><surname>Shah</surname><given-names>F</given-names></name><name><surname>Garg</surname><given-names>A</given-names></name><name><surname>Koós</surname><given-names>T</given-names></name><name><surname>Tepper</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Differential processing of thalamic information via distinct striatal interneuron circuits</article-title><source>Nature Communications</source><volume>8</volume><elocation-id>15860</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms15860</pub-id><pub-id pub-id-type="pmid">28604688</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Assous</surname><given-names>M</given-names></name><name><surname>Tepper</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Excitatory extrinsic afferents to striatal interneurons and interactions with striatal microcircuitry</article-title><source>The European Journal of Neuroscience</source><volume>49</volume><fpage>593</fpage><lpage>603</lpage><pub-id pub-id-type="doi">10.1111/ejn.13881</pub-id><pub-id pub-id-type="pmid">29480942</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Assous</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Striatal cholinergic transmission: Focus on nicotinic receptors’ influence in striatal circuits</article-title><source>The European Journal of Neuroscience</source><volume>53</volume><fpage>2421</fpage><lpage>2442</lpage><pub-id pub-id-type="doi">10.1111/ejn.15135</pub-id><pub-id pub-id-type="pmid">33529401</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bennett</surname><given-names>BD</given-names></name><name><surname>Wilson</surname><given-names>CJ</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Spontaneous activity of neostriatal cholinergic interneurons in vitro</article-title><source>The Journal of Neuroscience</source><volume>19</volume><fpage>5586</fpage><lpage>5596</lpage><pub-id pub-id-type="pmid">10377365</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bracci</surname><given-names>E</given-names></name><name><surname>Panzeri</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Excitatory GABAergic effects in striatal projection neurons</article-title><source>Journal of Neurophysiology</source><volume>95</volume><fpage>1285</fpage><lpage>1290</lpage><pub-id pub-id-type="doi">10.1152/jn.00598.2005</pub-id><pub-id pub-id-type="pmid">16251264</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bradfield</surname><given-names>LA</given-names></name><name><surname>Bertran-Gonzalez</surname><given-names>J</given-names></name><name><surname>Chieng</surname><given-names>B</given-names></name><name><surname>Balleine</surname><given-names>BW</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The thalamostriatal pathway and cholinergic control of goal-directed action: interlacing new with existing learning in the striatum</article-title><source>Neuron</source><volume>79</volume><fpage>153</fpage><lpage>166</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2013.04.039</pub-id><pub-id pub-id-type="pmid">23770257</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brimblecombe</surname><given-names>KR</given-names></name><name><surname>Cragg</surname><given-names>SJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The Striosome and Matrix Compartments of the Striatum: A Path through the Labyrinth from Neurochemistry toward Function</article-title><source>ACS Chemical Neuroscience</source><volume>8</volume><fpage>235</fpage><lpage>242</lpage><pub-id pub-id-type="doi">10.1021/acschemneuro.6b00333</pub-id><pub-id pub-id-type="pmid">27977131</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cachope</surname><given-names>R</given-names></name><name><surname>Mateo</surname><given-names>Y</given-names></name><name><surname>Mathur</surname><given-names>BN</given-names></name><name><surname>Irving</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>HL</given-names></name><name><surname>Morales</surname><given-names>M</given-names></name><name><surname>Lovinger</surname><given-names>DM</given-names></name><name><surname>Cheer</surname><given-names>JF</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Selective activation of cholinergic interneurons enhances accumbal phasic dopamine release: setting the tone for reward processing</article-title><source>Cell Reports</source><volume>2</volume><fpage>33</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2012.05.011</pub-id><pub-id pub-id-type="pmid">22840394</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calabresi</surname><given-names>P</given-names></name><name><surname>Centonze</surname><given-names>D</given-names></name><name><surname>Gubellini</surname><given-names>P</given-names></name><name><surname>Bernardi</surname><given-names>G</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Activation of M1-like muscarinic receptors is required for the induction of corticostriatal LTP</article-title><source>Neuropharmacology</source><volume>38</volume><fpage>323</fpage><lpage>326</lpage><pub-id pub-id-type="doi">10.1016/s0028-3908(98)00199-3</pub-id><pub-id pub-id-type="pmid">10218876</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Contant</surname><given-names>C</given-names></name><name><surname>Umbriaco</surname><given-names>D</given-names></name><name><surname>Garcia</surname><given-names>S</given-names></name><name><surname>Watkins</surname><given-names>KC</given-names></name><name><surname>Descarries</surname><given-names>L</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Ultrastructural characterization of the acetylcholine innervation in adult rat neostriatum</article-title><source>Neuroscience</source><volume>71</volume><fpage>937</fpage><lpage>947</lpage><pub-id pub-id-type="doi">10.1016/0306-4522(95)00507-2</pub-id><pub-id pub-id-type="pmid">8684624</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crittenden</surname><given-names>JR</given-names></name><name><surname>Lacey</surname><given-names>CJ</given-names></name><name><surname>Weng</surname><given-names>FJ</given-names></name><name><surname>Garrison</surname><given-names>CE</given-names></name><name><surname>Gibson</surname><given-names>DJ</given-names></name><name><surname>Lin</surname><given-names>Y</given-names></name><name><surname>Graybiel</surname><given-names>AM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Striatal Cholinergic Interneurons Modulate Spike-Timing in Striosomes and Matrix by an Amphetamine-Sensitive Mechanism</article-title><source>Frontiers in Neuroanatomy</source><volume>11</volume><elocation-id>20</elocation-id><pub-id pub-id-type="doi">10.3389/fnana.2017.00020</pub-id><pub-id pub-id-type="pmid">28377698</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dautan</surname><given-names>D</given-names></name><name><surname>Huerta-Ocampo</surname><given-names>I</given-names></name><name><surname>Gut</surname><given-names>NK</given-names></name><name><surname>Valencia</surname><given-names>M</given-names></name><name><surname>Kondabolu</surname><given-names>K</given-names></name><name><surname>Kim</surname><given-names>Y</given-names></name><name><surname>Gerdjikov</surname><given-names>TV</given-names></name><name><surname>Mena-Segovia</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Cholinergic midbrain afferents modulate striatal circuits and shape encoding of action strategies</article-title><source>Nature Communications</source><volume>11</volume><elocation-id>1739</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-020-15514-3</pub-id><pub-id pub-id-type="pmid">32269213</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Day</surname><given-names>M</given-names></name><name><surname>Wokosin</surname><given-names>D</given-names></name><name><surname>Plotkin</surname><given-names>JL</given-names></name><name><surname>Tian</surname><given-names>X</given-names></name><name><surname>Surmeier</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Differential excitability and modulation of striatal medium spiny neuron dendrites</article-title><source>The Journal of Neuroscience</source><volume>28</volume><fpage>11603</fpage><lpage>11614</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1840-08.2008</pub-id><pub-id pub-id-type="pmid">18987196</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DiFiglia</surname><given-names>M</given-names></name></person-group><year iso-8601-date="1987">1987</year><article-title>Synaptic organization of cholinergic neurons in the monkey neostriatum</article-title><source>The Journal of Comparative Neurology</source><volume>255</volume><fpage>245</fpage><lpage>258</lpage><pub-id pub-id-type="doi">10.1002/cne.902550208</pub-id><pub-id pub-id-type="pmid">3819015</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dorst</surname><given-names>MC</given-names></name><name><surname>Tokarska</surname><given-names>A</given-names></name><name><surname>Zhou</surname><given-names>M</given-names></name><name><surname>Lee</surname><given-names>K</given-names></name><name><surname>Stagkourakis</surname><given-names>S</given-names></name><name><surname>Broberger</surname><given-names>C</given-names></name><name><surname>Masmanidis</surname><given-names>S</given-names></name><name><surname>Silberberg</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Polysynaptic inhibition between striatal cholinergic interneurons shapes their network activity patterns in a dopamine-dependent manner</article-title><source>Nature Communications</source><volume>11</volume><elocation-id>5113</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-020-18882-y</pub-id><pub-id pub-id-type="pmid">33037215</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ebihara</surname><given-names>K</given-names></name><name><surname>Yamamoto</surname><given-names>K</given-names></name><name><surname>Ueda</surname><given-names>K</given-names></name><name><surname>Koshikawa</surname><given-names>N</given-names></name><name><surname>Kobayashi</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Cholinergic interneurons suppress action potential initiation of medium spiny neurons in rat nucleus accumbens shell</article-title><source>Neuroscience</source><volume>236</volume><fpage>332</fpage><lpage>344</lpage><pub-id pub-id-type="doi">10.1016/j.neuroscience.2013.01.012</pub-id><pub-id pub-id-type="pmid">23380504</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elghaba</surname><given-names>R</given-names></name><name><surname>Vautrelle</surname><given-names>N</given-names></name><name><surname>Bracci</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Mutual Control of Cholinergic and Low-Threshold Spike Interneurons in the Striatum</article-title><source>Frontiers in Cellular Neuroscience</source><volume>10</volume><elocation-id>111</elocation-id><pub-id pub-id-type="doi">10.3389/fncel.2016.00111</pub-id><pub-id pub-id-type="pmid">27199665</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>English</surname><given-names>DF</given-names></name><name><surname>Ibanez-Sandoval</surname><given-names>O</given-names></name><name><surname>Stark</surname><given-names>E</given-names></name><name><surname>Tecuapetla</surname><given-names>F</given-names></name><name><surname>Buzsáki</surname><given-names>G</given-names></name><name><surname>Deisseroth</surname><given-names>K</given-names></name><name><surname>Tepper</surname><given-names>JM</given-names></name><name><surname>Koos</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>GABAergic circuits mediate the reinforcement-related signals of striatal cholinergic interneurons</article-title><source>Nature Neuroscience</source><volume>15</volume><fpage>123</fpage><lpage>130</lpage><pub-id pub-id-type="doi">10.1038/nn.2984</pub-id><pub-id pub-id-type="pmid">22158514</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faust</surname><given-names>TW</given-names></name><name><surname>Assous</surname><given-names>M</given-names></name><name><surname>Shah</surname><given-names>F</given-names></name><name><surname>Tepper</surname><given-names>JM</given-names></name><name><surname>Koós</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Novel fast adapting interneurons mediate cholinergic-induced fast GABAA inhibitory postsynaptic currents in striatal spiny neurons</article-title><source>The European Journal of Neuroscience</source><volume>42</volume><fpage>1764</fpage><lpage>1774</lpage><pub-id pub-id-type="doi">10.1111/ejn.12915</pub-id><pub-id pub-id-type="pmid">25865337</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faust</surname><given-names>TW</given-names></name><name><surname>Assous</surname><given-names>M</given-names></name><name><surname>Tepper</surname><given-names>JM</given-names></name><name><surname>Koós</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Neostriatal GABAergic Interneurons Mediate Cholinergic Inhibition of Spiny Projection Neurons</article-title><source>The Journal of Neuroscience</source><volume>36</volume><fpage>9505</fpage><lpage>9511</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0466-16.2016</pub-id><pub-id pub-id-type="pmid">27605623</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flores-Barrera</surname><given-names>E</given-names></name><name><surname>Vizcarra-Chacón</surname><given-names>BJ</given-names></name><name><surname>Tapia</surname><given-names>D</given-names></name><name><surname>Bargas</surname><given-names>J</given-names></name><name><surname>Galarraga</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Different corticostriatal integration in spiny projection neurons from direct and indirect pathways</article-title><source>Frontiers in Systems Neuroscience</source><volume>4</volume><elocation-id>15</elocation-id><pub-id pub-id-type="doi">10.3389/fnsys.2010.00015</pub-id><pub-id pub-id-type="pmid">20589098</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gabel</surname><given-names>LA</given-names></name><name><surname>Nisenbaum</surname><given-names>ES</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Muscarinic receptors differentially modulate the persistent potassium current in striatal spiny projection neurons</article-title><source>Journal of Neurophysiology</source><volume>81</volume><fpage>1418</fpage><lpage>1423</lpage><pub-id pub-id-type="doi">10.1152/jn.1999.81.3.1418</pub-id><pub-id pub-id-type="pmid">10085367</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerfen</surname><given-names>CR</given-names></name><name><surname>Surmeier</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Modulation of striatal projection systems by dopamine</article-title><source>Annual Review of Neuroscience</source><volume>34</volume><fpage>441</fpage><lpage>466</lpage><pub-id pub-id-type="doi">10.1146/annurev-neuro-061010-113641</pub-id><pub-id pub-id-type="pmid">21469956</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gertler</surname><given-names>TS</given-names></name><name><surname>Chan</surname><given-names>CS</given-names></name><name><surname>Surmeier</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Dichotomous anatomical properties of adult striatal medium spiny neurons</article-title><source>The Journal of Neuroscience</source><volume>28</volume><fpage>10814</fpage><lpage>10824</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2660-08.2008</pub-id><pub-id pub-id-type="pmid">18945889</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gittis</surname><given-names>AH</given-names></name><name><surname>Nelson</surname><given-names>AB</given-names></name><name><surname>Thwin</surname><given-names>MT</given-names></name><name><surname>Palop</surname><given-names>JJ</given-names></name><name><surname>Kreitzer</surname><given-names>AC</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Distinct roles of GABAergic interneurons in the regulation of striatal output pathways</article-title><source>The Journal of Neuroscience</source><volume>30</volume><fpage>2223</fpage><lpage>2234</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.4870-09.2010</pub-id><pub-id pub-id-type="pmid">20147549</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gittis</surname><given-names>AH</given-names></name><name><surname>Leventhal</surname><given-names>DK</given-names></name><name><surname>Fensterheim</surname><given-names>BA</given-names></name><name><surname>Pettibone</surname><given-names>JR</given-names></name><name><surname>Berke</surname><given-names>JD</given-names></name><name><surname>Kreitzer</surname><given-names>AC</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Selective inhibition of striatal fast-spiking interneurons causes dyskinesias</article-title><source>The Journal of Neuroscience</source><volume>31</volume><fpage>15727</fpage><lpage>15731</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.3875-11.2011</pub-id><pub-id pub-id-type="pmid">22049415</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldberg</surname><given-names>JA</given-names></name><name><surname>Reynolds</surname><given-names>JNJ</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Spontaneous firing and evoked pauses in the tonically active cholinergic interneurons of the striatum</article-title><source>Neuroscience</source><volume>198</volume><fpage>27</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1016/j.neuroscience.2011.08.067</pub-id><pub-id pub-id-type="pmid">21925242</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldberg</surname><given-names>JA</given-names></name><name><surname>Ding</surname><given-names>JB</given-names></name><name><surname>Surmeier</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Muscarinic modulation of striatal function and circuitry</article-title><source>Experimental Pharmacology</source><volume>1</volume><fpage>223</fpage><lpage>241</lpage><pub-id pub-id-type="doi">10.1007/978-3-642-23274-9_10</pub-id><pub-id pub-id-type="pmid">22222701</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Graybiel</surname><given-names>AM</given-names></name><name><surname>Ragsdale</surname><given-names>CW</given-names></name></person-group><year iso-8601-date="1978">1978</year><article-title>Histochemically distinct compartments in the striatum of human, monkeys, and cat demonstrated by acetylthiocholinesterase staining</article-title><source>PNAS</source><volume>75</volume><fpage>5723</fpage><lpage>5726</lpage><pub-id pub-id-type="doi">10.1073/pnas.75.11.5723</pub-id><pub-id pub-id-type="pmid">103101</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gustafson</surname><given-names>N</given-names></name><name><surname>Gireesh-Dharmaraj</surname><given-names>E</given-names></name><name><surname>Czubayko</surname><given-names>U</given-names></name><name><surname>Blackwell</surname><given-names>KT</given-names></name><name><surname>Plenz</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>A comparative voltage and current-clamp analysis of feedback and feedforward synaptic transmission in the striatal microcircuit in vitro</article-title><source>Journal of Neurophysiology</source><volume>95</volume><fpage>737</fpage><lpage>752</lpage><pub-id pub-id-type="doi">10.1152/jn.00802.2005</pub-id><pub-id pub-id-type="pmid">16236782</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hao</surname><given-names>J</given-names></name><name><surname>Oertner</surname><given-names>TG</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Depolarization gates spine calcium transients and spike-timing-dependent potentiation</article-title><source>Current Opinion in Neurobiology</source><volume>22</volume><fpage>509</fpage><lpage>515</lpage><pub-id pub-id-type="doi">10.1016/j.conb.2011.10.004</pub-id><pub-id pub-id-type="pmid">22051693</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Higgs</surname><given-names>MH</given-names></name><name><surname>Wilson</surname><given-names>CJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Measurement of phase resetting curves using optogenetic barrage stimuli</article-title><source>Journal of Neuroscience Methods</source><volume>289</volume><fpage>23</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1016/j.jneumeth.2017.06.018</pub-id><pub-id pub-id-type="pmid">28668267</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ibáñez-Sandoval</surname><given-names>O</given-names></name><name><surname>Xenias</surname><given-names>HS</given-names></name><name><surname>Tepper</surname><given-names>JM</given-names></name><name><surname>Koós</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Dopaminergic and cholinergic modulation of striatal tyrosine hydroxylase interneurons</article-title><source>Neuropharmacology</source><volume>95</volume><fpage>468</fpage><lpage>476</lpage><pub-id pub-id-type="doi">10.1016/j.neuropharm.2015.03.036</pub-id><pub-id pub-id-type="pmid">25908399</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johansson</surname><given-names>Y</given-names></name><name><surname>Silberberg</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The Functional Organization of Cortical and Thalamic Inputs onto Five Types of Striatal Neurons Is Determined by Source and Target Cell Identities</article-title><source>Cell Reports</source><volume>30</volume><fpage>1178</fpage><lpage>1194</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2019.12.095</pub-id><pub-id pub-id-type="pmid">31995757</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kimura</surname><given-names>M</given-names></name><name><surname>Rajkowski</surname><given-names>J</given-names></name><name><surname>Evarts</surname><given-names>E</given-names></name></person-group><year iso-8601-date="1984">1984</year><article-title>Tonically discharging putamen neurons exhibit set-dependent responses</article-title><source>PNAS</source><volume>81</volume><fpage>4998</fpage><lpage>5001</lpage><pub-id pub-id-type="doi">10.1073/pnas.81.15.4998</pub-id><pub-id pub-id-type="pmid">6589643</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koós</surname><given-names>T</given-names></name><name><surname>Tepper</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Inhibitory control of neostriatal projection neurons by GABAergic interneurons</article-title><source>Nature Neuroscience</source><volume>2</volume><fpage>467</fpage><lpage>472</lpage><pub-id pub-id-type="doi">10.1038/8138</pub-id><pub-id pub-id-type="pmid">10321252</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koós</surname><given-names>T</given-names></name><name><surname>Tepper</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Dual cholinergic control of fast-spiking interneurons in the neostriatum</article-title><source>The Journal of Neuroscience</source><volume>22</volume><fpage>529</fpage><lpage>535</lpage><pub-id pub-id-type="pmid">11784799</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lapper</surname><given-names>SR</given-names></name><name><surname>Bolam</surname><given-names>JP</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>Input from the frontal cortex and the parafascicular nucleus to cholinergic interneurons in the dorsal striatum of the rat</article-title><source>Neuroscience</source><volume>51</volume><fpage>533</fpage><lpage>545</lpage><pub-id pub-id-type="doi">10.1016/0306-4522(92)90293-b</pub-id><pub-id pub-id-type="pmid">1488113</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Licheri</surname><given-names>V</given-names></name><name><surname>Lagström</surname><given-names>O</given-names></name><name><surname>Lotfi</surname><given-names>A</given-names></name><name><surname>Patton</surname><given-names>MH</given-names></name><name><surname>Wigström</surname><given-names>H</given-names></name><name><surname>Mathur</surname><given-names>B</given-names></name><name><surname>Adermark</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Complex Control of Striatal Neurotransmission by Nicotinic Acetylcholine Receptors via Excitatory Inputs onto Medium Spiny Neurons</article-title><source>The Journal of Neuroscience</source><volume>38</volume><fpage>6597</fpage><lpage>6607</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0071-18.2018</pub-id><pub-id pub-id-type="pmid">29941445</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Cai</surname><given-names>X</given-names></name><name><surname>Ritzau-Jost</surname><given-names>A</given-names></name><name><surname>Kramer</surname><given-names>PF</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Khaliq</surname><given-names>ZM</given-names></name><name><surname>Hallermann</surname><given-names>S</given-names></name><name><surname>Kaeser</surname><given-names>PS</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>An action potential initiation mechanism in distal axons for the control of dopamine release</article-title><source>Science (New York, N.Y.)</source><volume>375</volume><fpage>1378</fpage><lpage>1385</lpage><pub-id pub-id-type="doi">10.1126/science.abn0532</pub-id><pub-id pub-id-type="pmid">35324301</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname><given-names>R</given-names></name><name><surname>Janssen</surname><given-names>MJ</given-names></name><name><surname>Partridge</surname><given-names>JG</given-names></name><name><surname>Vicini</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Direct and GABA-mediated indirect effects of nicotinic ACh receptor agonists on striatal neurones</article-title><source>The Journal of Physiology</source><volume>591</volume><fpage>203</fpage><lpage>217</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.2012.241786</pub-id><pub-id pub-id-type="pmid">23045343</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mamaligas</surname><given-names>AA</given-names></name><name><surname>Barcomb</surname><given-names>K</given-names></name><name><surname>Ford</surname><given-names>CP</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Cholinergic Transmission at Muscarinic Synapses in the Striatum Is Driven Equally by Cortical and Thalamic Inputs</article-title><source>Cell Reports</source><volume>28</volume><fpage>1003</fpage><lpage>1014</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2019.06.077</pub-id><pub-id pub-id-type="pmid">31340139</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mesulam</surname><given-names>MM</given-names></name><name><surname>Mash</surname><given-names>D</given-names></name><name><surname>Hersh</surname><given-names>L</given-names></name><name><surname>Bothwell</surname><given-names>M</given-names></name><name><surname>Geula</surname><given-names>C</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>Cholinergic innervation of the human striatum, globus pallidus, subthalamic nucleus, substantia nigra, and red nucleus</article-title><source>The Journal of Comparative Neurology</source><volume>323</volume><fpage>252</fpage><lpage>268</lpage><pub-id pub-id-type="doi">10.1002/cne.903230209</pub-id><pub-id pub-id-type="pmid">1401259</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morgenstern</surname><given-names>NA</given-names></name><name><surname>Isidro</surname><given-names>AF</given-names></name><name><surname>Israely</surname><given-names>I</given-names></name><name><surname>Costa</surname><given-names>RM</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Pyramidal tract neurons drive amplification of excitatory inputs to striatum through cholinergic interneurons</article-title><source>Science Advances</source><volume>8</volume><elocation-id>eabh4315</elocation-id><pub-id pub-id-type="doi">10.1126/sciadv.abh4315</pub-id><pub-id pub-id-type="pmid">35138902</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morris</surname><given-names>G</given-names></name><name><surname>Arkadir</surname><given-names>D</given-names></name><name><surname>Nevet</surname><given-names>A</given-names></name><name><surname>Vaadia</surname><given-names>E</given-names></name><name><surname>Bergman</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Coincident but distinct messages of midbrain dopamine and striatal tonically active neurons</article-title><source>Neuron</source><volume>43</volume><fpage>133</fpage><lpage>143</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2004.06.012</pub-id><pub-id pub-id-type="pmid">15233923</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muñoz-Manchado</surname><given-names>AB</given-names></name><name><surname>Foldi</surname><given-names>C</given-names></name><name><surname>Szydlowski</surname><given-names>S</given-names></name><name><surname>Sjulson</surname><given-names>L</given-names></name><name><surname>Farries</surname><given-names>M</given-names></name><name><surname>Wilson</surname><given-names>C</given-names></name><name><surname>Silberberg</surname><given-names>G</given-names></name><name><surname>Hjerling-Leffler</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Novel Striatal GABAergic Interneuron Populations Labeled in the 5HT3a(EGFP) Mouse</article-title><source>Cerebral Cortex (New York, N.Y</source><volume>26</volume><fpage>96</fpage><lpage>105</lpage><pub-id pub-id-type="doi">10.1093/cercor/bhu179</pub-id><pub-id pub-id-type="pmid">25146369</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muñoz-Manchado</surname><given-names>AB</given-names></name><name><surname>Bengtsson Gonzales</surname><given-names>C</given-names></name><name><surname>Zeisel</surname><given-names>A</given-names></name><name><surname>Munguba</surname><given-names>H</given-names></name><name><surname>Bekkouche</surname><given-names>B</given-names></name><name><surname>Skene</surname><given-names>NG</given-names></name><name><surname>Lönnerberg</surname><given-names>P</given-names></name><name><surname>Ryge</surname><given-names>J</given-names></name><name><surname>Harris</surname><given-names>KD</given-names></name><name><surname>Linnarsson</surname><given-names>S</given-names></name><name><surname>Hjerling-Leffler</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Diversity of Interneurons in the Dorsal Striatum Revealed by Single-Cell RNA Sequencing and PatchSeq</article-title><source>Cell Reports</source><volume>24</volume><fpage>2179</fpage><lpage>2190</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2018.07.053</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nelson</surname><given-names>AB</given-names></name><name><surname>Bussert</surname><given-names>TG</given-names></name><name><surname>Kreitzer</surname><given-names>AC</given-names></name><name><surname>Seal</surname><given-names>RP</given-names></name></person-group><year iso-8601-date="2014">2014a</year><article-title>Striatal cholinergic neurotransmission requires VGLUT3</article-title><source>The Journal of Neuroscience</source><volume>34</volume><fpage>8772</fpage><lpage>8777</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0901-14.2014</pub-id><pub-id pub-id-type="pmid">24966377</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nelson</surname><given-names>AB</given-names></name><name><surname>Hammack</surname><given-names>N</given-names></name><name><surname>Yang</surname><given-names>CF</given-names></name><name><surname>Shah</surname><given-names>NM</given-names></name><name><surname>Seal</surname><given-names>RP</given-names></name><name><surname>Kreitzer</surname><given-names>AC</given-names></name></person-group><year iso-8601-date="2014">2014b</year><article-title>Striatal cholinergic interneurons Drive GABA release from dopamine terminals</article-title><source>Neuron</source><volume>82</volume><fpage>63</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2014.01.023</pub-id><pub-id pub-id-type="pmid">24613418</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pakhotin</surname><given-names>P</given-names></name><name><surname>Bracci</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Cholinergic interneurons control the excitatory input to the striatum</article-title><source>The Journal of Neuroscience</source><volume>27</volume><fpage>391</fpage><lpage>400</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.3709-06.2007</pub-id><pub-id pub-id-type="pmid">17215400</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname><given-names>WX</given-names></name><name><surname>Brown</surname><given-names>J</given-names></name><name><surname>Dudman</surname><given-names>JT</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Neural signals of extinction in the inhibitory microcircuit of the ventral midbrain</article-title><source>Nature Neuroscience</source><volume>16</volume><fpage>71</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.1038/nn.3283</pub-id><pub-id pub-id-type="pmid">23222913</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pawlak</surname><given-names>V</given-names></name><name><surname>Kerr</surname><given-names>JND</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Dopamine receptor activation is required for corticostriatal spike-timing-dependent plasticity</article-title><source>The Journal of Neuroscience</source><volume>28</volume><fpage>2435</fpage><lpage>2446</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.4402-07.2008</pub-id><pub-id pub-id-type="pmid">18322089</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Planert</surname><given-names>H</given-names></name><name><surname>Szydlowski</surname><given-names>SN</given-names></name><name><surname>Hjorth</surname><given-names>JJJ</given-names></name><name><surname>Grillner</surname><given-names>S</given-names></name><name><surname>Silberberg</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Dynamics of synaptic transmission between fast-spiking interneurons and striatal projection neurons of the direct and indirect pathways</article-title><source>The Journal of Neuroscience</source><volume>30</volume><fpage>3499</fpage><lpage>3507</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.5139-09.2010</pub-id><pub-id pub-id-type="pmid">20203210</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plotkin</surname><given-names>JL</given-names></name><name><surname>Goldberg</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Thinking Outside the Box (and Arrow): Current Themes in Striatal Dysfunction in Movement Disorders</article-title><source>The Neuroscientist</source><volume>25</volume><fpage>359</fpage><lpage>379</lpage><pub-id pub-id-type="doi">10.1177/1073858418807887</pub-id><pub-id pub-id-type="pmid">30379121</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poppi</surname><given-names>LA</given-names></name><name><surname>Ho-Nguyen</surname><given-names>KT</given-names></name><name><surname>Shi</surname><given-names>A</given-names></name><name><surname>Daut</surname><given-names>CT</given-names></name><name><surname>Tischfield</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Recurrent Implication of Striatal Cholinergic Interneurons in a Range of Neurodevelopmental, Neurodegenerative, and Neuropsychiatric Disorders</article-title><source>Cells</source><volume>10</volume><elocation-id>907</elocation-id><pub-id pub-id-type="doi">10.3390/cells10040907</pub-id><pub-id pub-id-type="pmid">33920757</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prager</surname><given-names>EM</given-names></name><name><surname>Plotkin</surname><given-names>JL</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Compartmental function and modulation of the striatum</article-title><source>Journal of Neuroscience Research</source><volume>97</volume><fpage>1503</fpage><lpage>1514</lpage><pub-id pub-id-type="doi">10.1002/jnr.24522</pub-id><pub-id pub-id-type="pmid">31489687</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raz</surname><given-names>A</given-names></name><name><surname>Feingold</surname><given-names>A</given-names></name><name><surname>Zelanskaya</surname><given-names>V</given-names></name><name><surname>Vaadia</surname><given-names>E</given-names></name><name><surname>Bergman</surname><given-names>H</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Neuronal synchronization of tonically active neurons in the striatum of normal and parkinsonian primates</article-title><source>Journal of Neurophysiology</source><volume>76</volume><fpage>2083</fpage><lpage>2088</lpage><pub-id pub-id-type="doi">10.1152/jn.1996.76.3.2083</pub-id><pub-id pub-id-type="pmid">8890317</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reynolds</surname><given-names>JNJ</given-names></name><name><surname>Avvisati</surname><given-names>R</given-names></name><name><surname>Dodson</surname><given-names>PD</given-names></name><name><surname>Fisher</surname><given-names>SD</given-names></name><name><surname>Oswald</surname><given-names>MJ</given-names></name><name><surname>Wickens</surname><given-names>JR</given-names></name><name><surname>Zhang</surname><given-names>YF</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Coincidence of cholinergic pauses, dopaminergic activation and depolarisation of spiny projection neurons drives synaptic plasticity in the striatum</article-title><source>Nature Communications</source><volume>13</volume><elocation-id>1296</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-022-28950-0</pub-id><pub-id pub-id-type="pmid">35277506</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rice</surname><given-names>ME</given-names></name><name><surname>Cragg</surname><given-names>SJ</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Nicotine amplifies reward-related dopamine signals in striatum</article-title><source>Nature Neuroscience</source><volume>7</volume><fpage>583</fpage><lpage>584</lpage><pub-id pub-id-type="doi">10.1038/nn1244</pub-id><pub-id pub-id-type="pmid">15146188</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rock</surname><given-names>C</given-names></name><name><surname>Zurita</surname><given-names>H</given-names></name><name><surname>Wilson</surname><given-names>C</given-names></name><name><surname>Apicella</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>An inhibitory corticostriatal pathway</article-title><source>eLife</source><volume>5</volume><elocation-id>e15890</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.15890</pub-id><pub-id pub-id-type="pmid">27159237</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>W</given-names></name><name><surname>Flajolet</surname><given-names>M</given-names></name><name><surname>Greengard</surname><given-names>P</given-names></name><name><surname>Surmeier</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Dichotomous dopaminergic control of striatal synaptic plasticity</article-title><source>Science (New York, N.Y.)</source><volume>321</volume><fpage>848</fpage><lpage>851</lpage><pub-id pub-id-type="doi">10.1126/science.1160575</pub-id><pub-id pub-id-type="pmid">18687967</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shuen</surname><given-names>JA</given-names></name><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>Gloss</surname><given-names>B</given-names></name><name><surname>Calakos</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Drd1a-tdTomato BAC transgenic mice for simultaneous visualization of medium spiny neurons in the direct and indirect pathways of the basal ganglia</article-title><source>The Journal of Neuroscience</source><volume>28</volume><fpage>2681</fpage><lpage>2685</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.5492-07.2008</pub-id><pub-id pub-id-type="pmid">18337395</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silberberg</surname><given-names>G</given-names></name><name><surname>Bolam</surname><given-names>JP</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Local and afferent synaptic pathways in the striatal microcircuitry</article-title><source>Current Opinion in Neurobiology</source><volume>33</volume><fpage>182</fpage><lpage>187</lpage><pub-id pub-id-type="doi">10.1016/j.conb.2015.05.002</pub-id><pub-id pub-id-type="pmid">26051382</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Solinas</surname><given-names>M</given-names></name><name><surname>Scherma</surname><given-names>M</given-names></name><name><surname>Fattore</surname><given-names>L</given-names></name><name><surname>Stroik</surname><given-names>J</given-names></name><name><surname>Wertheim</surname><given-names>C</given-names></name><name><surname>Tanda</surname><given-names>G</given-names></name><name><surname>Fratta</surname><given-names>W</given-names></name><name><surname>Goldberg</surname><given-names>SR</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Nicotinic alpha 7 receptors as a new target for treatment of cannabis abuse</article-title><source>The Journal of Neuroscience</source><volume>27</volume><fpage>5615</fpage><lpage>5620</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0027-07.2007</pub-id><pub-id pub-id-type="pmid">17522306</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stern</surname><given-names>EA</given-names></name><name><surname>Jaeger</surname><given-names>D</given-names></name><name><surname>Wilson</surname><given-names>CJ</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Membrane potential synchrony of simultaneously recorded striatal spiny neurons in vivo</article-title><source>Nature</source><volume>394</volume><fpage>475</fpage><lpage>478</lpage><pub-id pub-id-type="doi">10.1038/28848</pub-id><pub-id pub-id-type="pmid">9697769</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanimura</surname><given-names>A</given-names></name><name><surname>Lim</surname><given-names>SAO</given-names></name><name><surname>Aceves Buendia</surname><given-names>JDJ</given-names></name><name><surname>Goldberg</surname><given-names>JA</given-names></name><name><surname>Surmeier</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Cholinergic Interneurons Amplify Corticostriatal Synaptic Responses in the Q175 Model of Huntington’s Disease</article-title><source>Frontiers in Systems Neuroscience</source><volume>10</volume><elocation-id>102</elocation-id><pub-id pub-id-type="doi">10.3389/fnsys.2016.00102</pub-id><pub-id pub-id-type="pmid">28018188</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tepper</surname><given-names>JM</given-names></name><name><surname>Bolam</surname><given-names>JP</given-names></name></person-group><year iso-8601-date="2004">2004a</year><article-title>Functional diversity and specificity of neostriatal interneurons</article-title><source>Current Opinion in Neurobiology</source><volume>14</volume><fpage>685</fpage><lpage>692</lpage><pub-id pub-id-type="doi">10.1016/j.conb.2004.10.003</pub-id><pub-id pub-id-type="pmid">15582369</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tepper</surname><given-names>JM</given-names></name><name><surname>Koós</surname><given-names>T</given-names></name><name><surname>Wilson</surname><given-names>CJ</given-names></name></person-group><year iso-8601-date="2004">2004b</year><article-title>GABAergic microcircuits in the neostriatum</article-title><source>Trends in Neurosciences</source><volume>27</volume><fpage>662</fpage><lpage>669</lpage><pub-id pub-id-type="doi">10.1016/j.tins.2004.08.007</pub-id><pub-id pub-id-type="pmid">15474166</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tepper</surname><given-names>JM</given-names></name><name><surname>Tecuapetla</surname><given-names>F</given-names></name><name><surname>Koós</surname><given-names>T</given-names></name><name><surname>Ibáñez-Sandoval</surname><given-names>O</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Heterogeneity and diversity of striatal GABAergic interneurons</article-title><source>Frontiers in Neuroanatomy</source><volume>4</volume><elocation-id>150</elocation-id><pub-id pub-id-type="doi">10.3389/fnana.2010.00150</pub-id><pub-id pub-id-type="pmid">21228905</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tepper</surname><given-names>JM</given-names></name><name><surname>Koós</surname><given-names>T</given-names></name><name><surname>Ibanez-Sandoval</surname><given-names>O</given-names></name><name><surname>Tecuapetla</surname><given-names>F</given-names></name><name><surname>Faust</surname><given-names>TW</given-names></name><name><surname>Assous</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Heterogeneity and Diversity of Striatal GABAergic Interneurons: Update 2018</article-title><source>Frontiers in Neuroanatomy</source><volume>12</volume><elocation-id>91</elocation-id><pub-id pub-id-type="doi">10.3389/fnana.2018.00091</pub-id><pub-id pub-id-type="pmid">30467465</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>TM</given-names></name><name><surname>Smith</surname><given-names>Y</given-names></name><name><surname>Levey</surname><given-names>AI</given-names></name><name><surname>Hersch</surname><given-names>SM</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Cortical inputs to m2-immunoreactive striatal interneurons in rat and monkey</article-title><source>Synapse (New York, N.Y.)</source><volume>37</volume><fpage>252</fpage><lpage>261</lpage><pub-id pub-id-type="doi">10.1002/1098-2396(20000915)37:4&lt;252::AID-SYN2&gt;3.0.CO;2-A</pub-id><pub-id pub-id-type="pmid">10891862</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Threlfell</surname><given-names>S</given-names></name><name><surname>Lalic</surname><given-names>T</given-names></name><name><surname>Platt</surname><given-names>NJ</given-names></name><name><surname>Jennings</surname><given-names>KA</given-names></name><name><surname>Deisseroth</surname><given-names>K</given-names></name><name><surname>Cragg</surname><given-names>SJ</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Striatal dopamine release is triggered by synchronized activity in cholinergic interneurons</article-title><source>Neuron</source><volume>75</volume><fpage>58</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2012.04.038</pub-id><pub-id pub-id-type="pmid">22794260</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tiroshi</surname><given-names>L</given-names></name><name><surname>Goldberg</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Population dynamics and entrainment of basal ganglia pacemakers are shaped by their dendritic arbors</article-title><source>PLOS Computational Biology</source><volume>15</volume><elocation-id>e1006782</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1006782</pub-id><pub-id pub-id-type="pmid">30730886</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>CJ</given-names></name><name><surname>Groves</surname><given-names>PM</given-names></name></person-group><year iso-8601-date="1981">1981</year><article-title>Spontaneous firing patterns of identified spiny neurons in the rat neostriatum</article-title><source>Brain Research</source><volume>220</volume><fpage>67</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1016/0006-8993(81)90211-0</pub-id><pub-id pub-id-type="pmid">6168334</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>CJ</given-names></name><name><surname>Xu</surname><given-names>ZC</given-names></name><name><surname>Emson</surname><given-names>PC</given-names></name><name><surname>Feler</surname><given-names>C</given-names></name></person-group><year iso-8601-date="1990">1990</year><article-title>Anatomical and physiological properties of the cortical and thalamic innervations of neostriatal tissue grafts</article-title><source>Progress in Brain Research</source><volume>82</volume><fpage>417</fpage><lpage>426</lpage><pub-id pub-id-type="doi">10.1016/s0079-6123(08)62630-8</pub-id><pub-id pub-id-type="pmid">2290955</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Witten</surname><given-names>IB</given-names></name><name><surname>Lin</surname><given-names>SC</given-names></name><name><surname>Brodsky</surname><given-names>M</given-names></name><name><surname>Prakash</surname><given-names>R</given-names></name><name><surname>Diester</surname><given-names>I</given-names></name><name><surname>Anikeeva</surname><given-names>P</given-names></name><name><surname>Gradinaru</surname><given-names>V</given-names></name><name><surname>Ramakrishnan</surname><given-names>C</given-names></name><name><surname>Deisseroth</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Cholinergic interneurons control local circuit activity and cocaine conditioning</article-title><source>Science (New York, N.Y.)</source><volume>330</volume><fpage>1677</fpage><lpage>1681</lpage><pub-id pub-id-type="doi">10.1126/science.1193771</pub-id><pub-id pub-id-type="pmid">21164015</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>FM</given-names></name><name><surname>Liang</surname><given-names>Y</given-names></name><name><surname>Dani</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Endogenous nicotinic cholinergic activity regulates dopamine release in the striatum</article-title><source>Nature Neuroscience</source><volume>4</volume><fpage>1224</fpage><lpage>1229</lpage><pub-id pub-id-type="doi">10.1038/nn769</pub-id><pub-id pub-id-type="pmid">11713470</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>FM</given-names></name><name><surname>Wilson</surname><given-names>CJ</given-names></name><name><surname>Dani</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Cholinergic interneuron characteristics and nicotinic properties in the striatum</article-title><source>Journal of Neurobiology</source><volume>53</volume><fpage>590</fpage><lpage>605</lpage><pub-id pub-id-type="doi">10.1002/neu.10150</pub-id><pub-id pub-id-type="pmid">12436423</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zucca</surname><given-names>S</given-names></name><name><surname>Zucca</surname><given-names>A</given-names></name><name><surname>Nakano</surname><given-names>T</given-names></name><name><surname>Aoki</surname><given-names>S</given-names></name><name><surname>Wickens</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Pauses in cholinergic interneuron firing exert an inhibitory control on striatal output in vivo</article-title><source>eLife</source><volume>7</volume><elocation-id>e32510</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.32510</pub-id><pub-id pub-id-type="pmid">29578407</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.75829.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Ding</surname><given-names>Jun</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00f54p054</institution-id><institution>Stanford University</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><related-object id="sa0ro1" link-type="continued-by" object-id="10.1101/2021.11.02.466870" object-id-type="id" xlink:href="https://sciety.org/articles/activity/10.1101/2021.11.02.466870"/></front-stub><body><p>Matityahu et al., investigate the influence of nicotinic acetylcholine receptor signaling on striatal microcircuit function through a combination of slice electrophysiology, optogenetics, and pharmacology. They find that nicotinic signaling delays spiking of striatal projection neurons in response to excitatory input, likely through the tonic release of acetylcholine by cholinergic interneurons onto local GABAergic interneurons and their influence on striatal projection neurons. Understanding how acetylcholine shapes striatal circuits is important, as this neurotransmitter is implicated in multiple movement disorders as well as other basal ganglia-related diseases.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.75829.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Ding</surname><given-names>Jun</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00f54p054</institution-id><institution>Stanford University</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Zhou</surname><given-names>Fu-Ming</given-names></name><role>Reviewer</role></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>Our editorial process produces two outputs: i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2021.11.02.466870">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2021.11.02.466870v3">the preprint</ext-link> for the benefit of readers; ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Tonic engagement of nicotinic receptors bidirectionally controls striatal spiny projection neuron spike timing&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 3 peer reviewers, and the evaluation has been overseen by a Reviewing Editor and John Huguenard as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Fu-Ming Zhou (Reviewer #1).</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions:</p><p>1) Please provide sufficient and specific interpretation of the existing data. Some additional experiments are needed to make the conclusion more convincing, for example, increase n number, clearer definition of ADP. Please see Reviewer 1's detailed suggestions.</p><p>2) Reviewer 3 expressed concerns about using the Thy1-ChR2 line, and suggested using an additional cortical specific mouse line to strengthen the conclusion. The authors can either follow this suggestion to repeat some experiments using a new mouse line, or the authors can provide evidence showing expression of Thy1-ChR2 is restricted in cortical excitatory neurons (histology) and measure the latencies for excitatory vs inhibitory responses to verify there are no monosynaptic inhibitory components.</p><p>3) The authors highlight a mechanism by which cortical excitation would engage cholinergic and GABAergic neurons ending in GIN-mediated delay of spiking in SPNs. But they do relatively little to identify which GABAergic cell types are likely to contribute. They look specifically at how DHBE increases the excitability of PV-FSI, but provide neither direct evidence for PV-FSI nor rule our other cell types. Additional experiments are essential to address this major concern.</p><p>4) Please conduct PPR experiments for MLA and add the results in Figure 2.</p><p>5) Please provide data where it says &quot;data not shown&quot;.</p><p>6) Reviewers provided detailed suggestions, and all reviewers agree that these are reasonable, please edit accordingly.</p><p><italic>Reviewer #1 (Recommendations for the authors):</italic></p><p>&quot;Engagement&quot; is used many times in the text. But this word is not informative. &quot;engagement of nicotinic receptors&quot; (used in the title) is not even logical: a receptor is either activated or inactivated or inhibited. &quot;Spike advancement&quot; is similarly problematic.</p><p>I suggest that the authors make a summary diagram, helping the reader understand their new findings.</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>1. The authors state &quot;To interrogate microcircuit-level responses of SPNs to cortical excitation of the striatum, we generated acute ex vivo brain slices from Thy1-ChR2 mice.&quot; The Thy1-ChR2 mouse line was originally billed as expressing ChR2 in excitatory cortical projection neurons, but this expression is not limited to cortical projection neurons. Even modest expression of ChR2 in other types of neurons, especially GABAergic neurons, could influence the results the authors show in Figures 1, 2, and 3, since they are using terminal field stimulation in the striatum. It also could influence the interpretation of the microcircuits engaged. Though not every experiment in the paper relies on this line, several do, so it would be helpful to (a) show by histology where expression is and is not present, perhaps even looking for GABAergic neurons amongst those ChR2-expressing neurons in the cortex in the line, (b) determine the timing of any GABAergic versus expected glutamatergic components of monosynaptic inputs to the striatum in the Thy1-ChR2 line, for example by measuring the latency to the first deflection from the onset of an optical stimulus, and (c) validate that the same change in spike delay can be seen with an approach targeted specifically to excitatory cortical projection neurons, such as using a Cre recombinase line selective for these neurons and a focal injection of Cre-dependent ChR2 in one of the cortical areas that projects to their recording site.</p><p>2. The authors' logic is not watertight in a paragraph about potential sources of IPSCs to SPNs and their modulation. SPNs receive inhibitory input from (at minimum) other SPNs, fast-spiking interneurons, various types of other GABAergic interneurons, and dopamine neurons, as the authors note. They then state &quot;SPNs are quiescent in acute slices and lack nAChRs, the source of these attenuated sIPSCs is likely GINs.&quot; However, sIPSCs are often (including in the striatum) a mixture of mIPSCs (spontaneous fusion events, not action potential-dependent) and action potential-dependent release. Though SPNs and fast-spiking interneurons are typically highly hyperpolarized in the slice preparation, they do contribute to mIPSCs and to the total sIPSCs recorded. The action potential-dependent sources are more likely to be from spontaneously firing GINs, such as the low-threshold-spiking types, or from axo-axonic/disynaptic release events driven by spontaneously active populations. In the same section, the authors state &quot;Because PV-FSIs convey strong feedforward inhibition to SPNs (Koós and Tepper 1999, Tepper, Koós et al., 2004, Planert, Szydlowski et al., 2010), but do not respond to phasic CIN (English, Ibanez-Sandoval et al., 2011)&quot;…This point is brought up again in the Discussion. However, in the cited paper, English et al., do not say that PV-FSI do not respond to optical stimulation of CIN, merely that they don't have large responses (in that paper they say there are no responses measured in current clamp of &gt;3 mV). In another paper, measurements in voltage-clamp also showed modest nicotinic responses in PV-FSI of about 20 pA (Nelson, Bussert et al., 2014), also indicating such responses are small, but not nonexistent. Given the authors' findings, in fact the high tonic activity of CINs in slice preparations at physiological temperatures, that may be why English et al., and Nelson et al., found relatively modest responses to phasic activation. These points do not take away at all from the authors findings, but the language in the Results and Discussion could be made more precise/accurate.</p><p>3. The authors highlight a mechanism by which (presumed) cortical excitation would engage cholinergic and GABAergic neurons ending in GIN-mediated delay of spiking in SPNs. But they do relatively little to identify which GABAergic cell types are likely to contribute. They look specifically at how DHBE increases excitability of PV-FSI, which is suggestive, but provide neither direct evidence for PV-FSI nor rule our other cell types. The role of specific GABAergic interneurons could be shown more directly by manipulations of PV-FSI (or other cell types) within their microcircuit activation protocol. These could include PV-specific chemogenetic/optogenetic manipulations, or Cre-dependent cell killing methods, or possibly use of drugs that specifically inhibit Ca-permeable AMPA receptors, such as are found on PV-FSI in the striatum (though I am not sure if these types of AMPA receptors might also be expressed on CIN) (Gittis et al., J. Neurosci 2010; Gittis et al., J. Neurosci 2011).</p><p><italic>Reviewer #3 (Recommendations for the authors):</italic></p><p>1) Please add DhβE data in Figure 1 instead of &quot;data not shown&quot;.</p><p>2) Please conduct PPR experiments for MLA and add the results in Figure 2.</p><p>3) Figure 5. Indicates &quot;phasic activation of CINs cannot explain the nAChR-dependent delay of spike latency&quot;. This is not clear or straightforward to the reviewer. Please describe and explain more clearly in the text.</p><p>4) Please add Witten et al., 2010, PMID: 21164015 in the discussion.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.75829.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1) Please provide sufficient and specific interpretation of the existing data. Some additional experiments are needed to make the conclusion more convincing, for example, increase n number, clearer definition of ADP. Please see Reviewer 1's detailed suggestions.</p></disp-quote><p>We have addressed all of these comments in our revised manuscript, which we believe is now significantly stronger. Please see our point-by-point responses to Reviewer 1 below.</p><disp-quote content-type="editor-comment"><p>2) Reviewer 3 expressed concerns about using the Thy1-ChR2 line, and suggested using an additional cortical specific mouse line to strengthen the conclusion. The authors can either follow this suggestion to repeat some experiments using a new mouse line, or the authors can provide evidence showing expression of Thy1-ChR2 is restricted in cortical excitatory neurons (histology) and measure the latencies for excitatory vs inhibitory responses to verify there are no monosynaptic inhibitory components.</p></disp-quote><p>We appreciate this concern, and have addressed it experimentally with several new sets of data. We have added immunohistochemical data demonstrating that we see no evidence for ChR2 expression in GABAergic neurons in the cortex. That said, we did observe ChR2 in a population of pallidal neurons, as well as a detectible monosynaptic IPSC in SPNs in response to optogenetic stimulation. We present new data showing that this direct GABAergic input, however, is 1) non-cortical and extrastriatal in origin, 2) insensitive to nAChR blockade and 3) does not contribute to role of tonic nAChR activation in delaying cortically-driven SPN spike latency or ADPs. Please see our point-by-point responses to the Reviewers below.</p><disp-quote content-type="editor-comment"><p>3) The authors highlight a mechanism by which cortical excitation would engage cholinergic and GABAergic neurons ending in GIN-mediated delay of spiking in SPNs. But they do relatively little to identify which GABAergic cell types are likely to contribute. They look specifically at how DHBE increases the excitability of PV-FSI, but provide neither direct evidence for PV-FSI nor rule our other cell types. Additional experiments are essential to address this major concern.</p></disp-quote><p>We agree that our initial submitted manuscript made minimal attempt to identify the type of GINs responsible for mediating the effect of tonic nAChR activation on SPN spike latency. We have added 2 sets of new data to rectify this. First, we provide new data showing that blocking tonically activated nAChRs affects two different classes of GINs (PV-FSI and SOM+ interneurons) in different and opposing ways (with the impact on SOM+ interneurons not consistent with a role for them mediating our observed effect on SPN spike latency). Second, we added a new experiment – which was aptly suggested by Reviewer 2 – where cortical activation of PV-FSIs (but not other GIN types such as PLTS interneurons) was pharmacologically prevented using a blocker of GluA2-lacking AMPA receptors. Blocking synaptic activation of PV-FSIs completely mimicked and occluded the effect of mecamylamine on SPN spike latency. Please see our point-by-point responses to the Reviewers below.</p><disp-quote content-type="editor-comment"><p>4) Please conduct PPR experiments for MLA and add the results in Figure 2.</p></disp-quote><p>We have added this data.</p><disp-quote content-type="editor-comment"><p>5) Please provide data where it says &quot;data not shown&quot;.</p></disp-quote><p>We have added this data.</p><disp-quote content-type="editor-comment"><p>6) Reviewers provided detailed suggestions, and all reviewers agree that these are reasonable, please edit accordingly.</p></disp-quote><p>We thank the Editor and Reviewers for their suggestions and efforts. We have edited accordingly, and believe our revised manuscript is significantly stronger.</p><disp-quote content-type="editor-comment"><p>Reviewer #1 (Recommendations for the authors):</p><p>&quot;Engagement&quot; is used many times in the text. But this word is not informative. &quot;engagement of nicotinic receptors&quot; (used in the title) is not even logical: a receptor is either activated or inactivated or inhibited. &quot;Spike advancement&quot; is similarly problematic.</p></disp-quote><p>We have corrected our useage of “engagement” and “spike advancement” throughout the manuscript. The title of the manuscript was altered as well.</p><disp-quote content-type="editor-comment"><p>I suggest that the authors make a summary diagram, helping the reader understand their new findings.</p></disp-quote><p>Excellent suggestion. We have added a summary diagram, which is now figure 9.</p><disp-quote content-type="editor-comment"><p>Reviewer #2 (Recommendations for the authors):</p><p>1. The authors state &quot;To interrogate microcircuit-level responses of SPNs to cortical excitation of the striatum, we generated acute ex vivo brain slices from Thy1-ChR2 mice.&quot; The Thy1-ChR2 mouse line was originally billed as expressing ChR2 in excitatory cortical projection neurons, but this expression is not limited to cortical projection neurons. Even modest expression of ChR2 in other types of neurons, especially GABAergic neurons, could influence the results the authors show in Figures 1, 2, and 3, since they are using terminal field stimulation in the striatum. It also could influence the interpretation of the microcircuits engaged. Though not every experiment in the paper relies on this line, several do, so it would be helpful to (a) show by histology where expression is and is not present, perhaps even looking for GABAergic neurons amongst those ChR2-expressing neurons in the cortex in the line, (b) determine the timing of any GABAergic versus expected glutamatergic components of monosynaptic inputs to the striatum in the Thy1-ChR2 line, for example by measuring the latency to the first deflection from the onset of an optical stimulus, and (c) validate that the same change in spike delay can be seen with an approach targeted specifically to excitatory cortical projection neurons, such as using a Cre recombinase line selective for these neurons and a focal injection of Cre-dependent ChR2 in one of the cortical areas that projects to their recording site.</p></disp-quote><p>Excellent points. We have added new data to address these concerns (please see our response to the Public Reviewer Comments; data is presented in figure 3 supplement and updated text on pages 7-8). Briefly, we added new histological data showing that we found no evidence for ChR2 expression in GABAergic neurons within the cortex, though we did observe some non-cortical and extrastriatal expression. New experiments discovered that, as the Reviewer implied may be the case, there is indeed a monosynaptic GABAergic current that is evoked in SPNs by our optogenetic stimulation protocol. We confirmed the monosynaptic nature of this input by pharmacologically blocking AMPA and NMDA receptors. Importantly, however, this GABAergic input is not sensitive to mecamylamine and so it is does not impact our results and interpretation of the microcircuits involved in the phenomenon we describe. Given the non-cortical and mecamylamine-insensitive nature of this direct GABAergic input, weighed against the cost and long delay it would take to import a cre-dependent cortical mouse line (and limited additional insight it would provide given our new data) we feel that the newly added data addresses the spirit of the Reviewer’s main concerns.</p><disp-quote content-type="editor-comment"><p>2. The authors' logic is not watertight in a paragraph about potential sources of IPSCs to SPNs and their modulation. SPNs receive inhibitory input from (at minimum) other SPNs, fast-spiking interneurons, various types of other GABAergic interneurons, and dopamine neurons, as the authors note. They then state &quot;SPNs are quiescent in acute slices and lack nAChRs, the source of these attenuated sIPSCs is likely GINs.&quot; However, sIPSCs are often (including in the striatum) a mixture of mIPSCs (spontaneous fusion events, not action potential-dependent) and action potential-dependent release. Though SPNs and fast-spiking interneurons are typically highly hyperpolarized in the slice preparation, they do contribute to mIPSCs and to the total sIPSCs recorded. The action potential-dependent sources are more likely to be from spontaneously firing GINs, such as the low-threshold-spiking types, or from axo-axonic/disynaptic release events driven by spontaneously active populations. In the same section, the authors state &quot;Because PV-FSIs convey strong feedforward inhibition to SPNs (Koós and Tepper 1999, Tepper, Koós et al., 2004, Planert, Szydlowski et al., 2010), but do not respond to phasic CIN (English, Ibanez-Sandoval et al., 2011)&quot;…This point is brought up again in the Discussion. However, in the cited paper, English et al., do not say that PV-FSI do not respond to optical stimulation of CIN, merely that they don’t have large responses (in that paper they say there are no responses measured in current clamp of &gt;3 mV). In another paper, measurements in voltage-clamp also showed modest nicotinic responses in PV-FSI of about 20 pA (Nelson, Bussert et al., 2014), also indicating such responses are small, but not nonexistent. Given the authors’ findings, in fact the high tonic activity of CINs in slice preparations at physiological temperatures, that may be why English et al., and Nelson et al., found relatively modest responses to phasic activation. These points do not take away at all from the authors findings, but the language in the Results and Discussion could be made more precise/accurate.</p></disp-quote><p>These are excellent and very insightful points. We have removed our implication that the hyperpolarized nature of SPNs may preclude them from contributing to the measured sIPSCs (which we agree the Reviewer is correct about) and, to exercise caution, remain agnostic about the class of GINs contributing to the iPSCs we observe. Thank you for correcting us on our description of transient nAChR-mediated responses in PV-FSIs. We have updated the text throughout to clarify that this class of GINs does indeed show responses to transient activation of nAChRs, albeit weak/modest. The Reviewer’s suggestion that tonic activation of nAChRs on PV-FSIs in slice recordings may explain why other groups have only found relatively modest responses to phasic activation of nAChRs is an excellent one, and we have added this (with references) to the text (second paragraph of the discussion).</p><disp-quote content-type="editor-comment"><p>3. The authors highlight a mechanism by which (presumed) cortical excitation would engage cholinergic and GABAergic neurons ending in GIN-mediated delay of spiking in SPNs. But they do relatively little to identify which GABAergic cell types are likely to contribute. They look specifically at how DHBE increases excitability of PV-FSI, which is suggestive, but provide neither direct evidence for PV-FSI nor rule our other cell types. The role of specific GABAergic interneurons could be shown more directly by manipulations of PV-FSI (or other cell types) within their microcircuit activation protocol. These could include PV-specific chemogenetic/optogenetic manipulations, or Cre-dependent cell killing methods, or possibly use of drugs that specifically inhibit Ca-permeable AMPA receptors, such as are found on PV-FSI in the striatum (though I am not sure if these types of AMPA receptors might also be expressed on CIN) (Gittis et al., J. Neurosci 2010; Gittis et al., J. Neurosci 2011).</p></disp-quote><p>As pointed out by the Reviewer, our initial attempt to pin the described mechanism on a particular class of GINs was minimal at best. We thank the reviewer for the outstanding suggestion of targeting PV-FSIs pharmacologically by blocking GluA2-lacking AMPA receptors (side note: because the phenomenon we examined does not require and occurs before the consequences of phasic CIN activation, the presence or absence of these AMPA receptors on CINs should have little consequence on our interpretation). We have added new data (figure 8) showing that blocking cortical activation of PV-FSIs both mimicked and occluded the effect of mecamylamine on spike latency, implicating this class of GINs as a primary mediator of the effect and excluding others (such as PLTS interneurons) as participants.</p><disp-quote content-type="editor-comment"><p>Reviewer #3 (Recommendations for the authors):</p><p>1) Please add DhβE data in Figure 1 instead of &quot;data not shown&quot;.</p></disp-quote><p>We have added this data, now shown in the supplement to figure 1.</p><disp-quote content-type="editor-comment"><p>2) Please conduct PPR experiments for MLA and add the results in Figure 2.</p></disp-quote><p>We have added this data, now shown in the supplement to figure 2.</p><disp-quote content-type="editor-comment"><p>3) Figure 5. Indicates &quot;phasic activation of CINs cannot explain the nAChR-dependent delay of spike latency&quot;. This is not clear or straightforward to the reviewer. Please describe and explain more clearly in the text.</p></disp-quote><p>We apologize for the confusion. Our reasoning was that the CIN-GIN-SPN disynaptic signal is too slow to mediate a change in spike latency on the time scale we report. We have clarified this text.</p><disp-quote content-type="editor-comment"><p>4) Please add Witten et al., 2010, PMID: 21164015 in the discussion.</p></disp-quote><p>We have added this reference (first paragraph of the discussion).</p></body></sub-article></article>